Latest / Pharmacy Podcast Network / The GCR Wake-Up Call: How Small Buying Decisions Are Crushing (or Saving) Pharmacy Margin | TWIRx
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 0:38Speaker 2: Now here's our host and founder of the Pharmacy Podcast Network, Todd.
- 0:43Speaker 3: You're welcome to this weekend.
- 0:45Speaker 1: Pharmacy Tworks is the number one weekly talk show about
- 0:49Speaker 1: the profession of pharmacy.
- 0:52Speaker 4: Hey hey, hey, yeah, yeah, yeah, yeah.
- 1:03Speaker 2: All right, I'm not gonna I'm not going to subject
- 1:06Speaker 2: you to some such horrible rapping. Not a rapper. We'll
- 1:12Speaker 2: never be a rapper. Welcome to this week in Pharmacy.
- 1:16Speaker 2: It is February six, twenty twenty six. If you didn't
- 1:20Speaker 2: know it was February already, it's February twenty twenty six.
- 1:26Speaker 2: It's going too best already. That's the way it goes.
- 1:31Speaker 2: I am excited to be here with you this week
- 1:34Speaker 2: in Pharmacy. We have a lot going on, a lot
- 1:36Speaker 2: to cover. We have two really special interviews that I
- 1:42Speaker 2: know that you're going to enjoy today. I enjoyed talking
- 1:45Speaker 2: with both of these dynamic and individuals and actually three
- 1:50Speaker 2: special people. And we're going to be talking with Johnny
- 1:54Speaker 2: Kello from the Sea. He's the CEO of match r X,
- 1:57Speaker 2: again he always brings us great information and ce Dino
- 2:02Speaker 2: who's his guest pharmacy operator pharmacist, and then a shout
- 2:06Speaker 2: out to Jonathan Adley, he's the CEO of tj M Labs.
- 2:12Speaker 2: You haven't heard about TJM Labs. You got to look
- 2:15Speaker 2: into them. It's all about artificial intelligence and the impact
- 2:18Speaker 2: on pharmacy and the pharmacy world. I'm excited to be
- 2:24Speaker 2: here with you. Like I said, there is so much
- 2:27Speaker 2: happening in our profession. If you are at all in
- 2:31Speaker 2: that boat that you think the profession is in disarray,
- 2:37Speaker 2: it's coming out of disarray and there's so much opportunity
- 2:42Speaker 2: out there right now. We're going to be talking about
- 2:43Speaker 2: a lot of it today. But first up, Workforce Strategy
- 2:47Speaker 2: for Independent Pharmacy Owners. What a great podcast that we
- 2:51Speaker 2: did with CEO of your Raal Pharma, Steven Beckman, who's
- 2:55Speaker 2: the host of The Executive Dose, and he digs into
- 2:59Speaker 2: this through a partnership with the Independent Pharmacy Cooperative and
- 3:04Speaker 2: their insights from Kelly as well as a pharmacy owner
- 3:09Speaker 2: Build Drilling, and they really talk about how this makes
- 3:15Speaker 2: a big impact the profession as well as to the
- 3:18Speaker 2: individual pharmacies or even a chain pharmacy and the importance
- 3:22Speaker 2: of workflows, workforce strategy and what that means for you
- 3:26Speaker 2: as a pharmacist and pharmacy owner. A shout out to
- 3:30Speaker 2: the Pharmacy Podcast Network. Thanks so much for a great
- 3:33Speaker 2: week of content. If you don't know, we're working with
- 3:36Speaker 2: GRX Marketing and Finch Marketing and you know what a
- 3:39Speaker 2: SWAT analysis is your strengths, your weaknesses, opportunities and threats.
- 3:46Speaker 2: Probably got that wrong, but mastering your SWAT analysis. Definitely
- 3:50Speaker 2: take a listen to that. It's a good show. Tamar Rugels,
- 3:54Speaker 2: doctor Rugles, is back and she has Debra Milto on
- 3:59Speaker 2: from from the Indiana, Pennsylvania area. And Deborah is a
- 4:07Speaker 2: long time friend of mine. She's the past president of
- 4:12Speaker 2: the American Society Consultant Pharmacists. I've worked with Deborah for
- 4:17Speaker 2: a short period of time directly and directly from Diamond
- 4:22Speaker 2: Pharmacy Services up in Indiana, Pennsylvania. It was great to
- 4:26Speaker 2: work with them over the years, and.
- 4:31Speaker 4: I'm just proud to know.
- 4:32Speaker 2: These people and what they're doing in the profession and
- 4:35Speaker 2: how they're making an impact to our profession. So take
- 4:38Speaker 2: a listen to that and it's very inspiring to listen
- 4:41Speaker 2: to the conversation with Deborah and with Tamrun. I really
- 4:47Speaker 2: enjoy it. I enjoy listening to the stars of our profession.
- 4:52Speaker 2: That's why I do what I do, all right, The
- 4:54Speaker 2: fifty most influential people in pharmacy, the awards, we've broken
- 4:58Speaker 2: that down into several pieces. We're putting one out every Saturday.
- 5:03Speaker 2: This was episode two of that four part series. If
- 5:05Speaker 2: you haven't listened, just the awards were so much fun
- 5:10Speaker 2: and we celebrate so many people that have made impacts
- 5:14Speaker 2: to our profession and I rise them up. I raised
- 5:19Speaker 2: them up and say thank you to all of you
- 5:23Speaker 2: who participated and who voted especially, and just thank you
- 5:28Speaker 2: so much. So February six, twenty twenty six, what's happening
- 5:33Speaker 2: in the industry. Well, first of all, retail report comes
- 5:38Speaker 2: out today from Credence Research Incorporated, and it says the
- 5:45Speaker 2: retail pharmacy market to reach one point nine seven trillion
- 5:50Speaker 2: by twenty thirty two, driven by the aging population, digital
- 5:55Speaker 2: health expansion. Once again from Credence, This just came out
- 5:59Speaker 2: today and it goes into the breakdown of their markets,
- 6:04Speaker 2: the breakdown of the percentage of growth as well as
- 6:07Speaker 2: they list some key growth drivers reshaping retail pharmacy, the
- 6:12Speaker 2: aging demographics, the strength of technology in place accelerated by
- 6:18Speaker 2: artificial intelligence, and e prescribing, e pharmacies, digital health. Just
- 6:24Speaker 2: a shout out to our listeners, how are you going
- 6:26Speaker 2: to play a part of this? How are you and
- 6:30Speaker 2: chain pharmacy or your independent pharmacy, your health systems, your
- 6:33Speaker 2: mail orders these online? How are you going to capitalize?
- 6:37Speaker 2: And we think we have people, we have organizations, we
- 6:42Speaker 2: have associations involved in this network for you to capitalize on.
- 6:47Speaker 2: If you ever wonder about any of that, you can
- 6:50Speaker 2: reach out to us. You can reach out to me,
- 6:52Speaker 2: you can even reach out to some of our hosts.
- 6:56Speaker 2: They're all accessible to you and just asking for advice,
- 7:00Speaker 2: especially if they're experts in something or one particular space
- 7:05Speaker 2: within pharmacy. But I think that's good news. One point
- 7:09Speaker 2: nine trillion as a market, inclusive market by twenty thirty two.
- 7:15Speaker 4: And I'm a small, tiny part of it. All right.
- 7:19Speaker 2: What about news coming off of the New York Post
- 7:24Speaker 2: just today in the headline is Walmart boost pay for
- 7:28Speaker 2: pharmacy staff with some jobs requiring no college degree. And
- 7:34Speaker 2: I don't think this is a surprise to people in
- 7:35Speaker 2: the industry, but it might be to the public of
- 7:38Speaker 2: being able to really grow and refine the quality of
- 7:42Speaker 2: our pharmacy technicians and our certified pharmacy technicians. We've done
- 7:47Speaker 2: several partnerships over the years with Mike Johnston's team over
- 7:51Speaker 2: at the National Pharmacy Technician Association. He actually made the
- 7:55Speaker 2: Pharmacy fifty list again. And how important our pharmacy techs
- 8:01Speaker 2: are in order to grow a new new pharmacy system,
- 8:06Speaker 2: a new pharmacy delivery model throughout the country, especially parts
- 8:10Speaker 2: of the United States that are suffering without pharmacy services.
- 8:14Speaker 2: And it says the Arkansas based retail giant, which recently
- 8:19Speaker 2: topped one trillion in market capitalization, says it employees about
- 8:26Speaker 2: thirty five thousand pharmacy technicians and fifteen thousand pharmacists across
- 8:32Speaker 2: about four thousand, six hundred pharmacies nationwide. Pharmacy Technicians previously
- 8:38Speaker 2: earned an average at twenty two dollars an hour, meaning
- 8:41Speaker 2: the new pay scale represents a potential increase of about
- 8:45Speaker 2: eighty four percent at the top end.
- 8:48Speaker 4: That is such good news.
- 8:50Speaker 2: This is Walmart said not all pharmacy workers will qualify
- 8:55Speaker 2: for the forty dollars forty dollars and fifty cent per
- 8:58Speaker 2: hour rate, while with salaries varying based on employee credentials
- 9:03Speaker 2: and locations, I still want to say congratulations to those
- 9:07Speaker 2: texts that might be listening out there.
- 9:10Speaker 4: You did make national news.
- 9:11Speaker 2: Pharmacy made national news, bringing to attention the quality of person,
- 9:16Speaker 2: the quality of work ethic, and the quality of your
- 9:19Speaker 2: knowledge and experience as a pharmacy technician.
- 9:22Speaker 4: You are not in fast food. You are in healthcare.
- 9:25Speaker 2: You are in pharmacy care, and you're an extremely important
- 9:29Speaker 2: part of the ecosystem of pharmacy. So good news to
- 9:33Speaker 2: hear out of drug topics. Just today headline Medicare reforms
- 9:39Speaker 2: aim to pay pharmacists for clinical care. Once again, Medicare
- 9:44Speaker 2: reforms aim to pay pharmacists for clinical care. And this
- 9:50Speaker 2: comes from Jim Lewis. He's the senior director of Policy
- 9:55Speaker 2: and Advocacy for the American Society Consultant Pharmacists, and he's
- 10:00Speaker 2: quoted in saying that Congress is debating whether or not
- 10:03Speaker 2: it's going to pass the funding bill that includes some
- 10:07Speaker 2: PBM provisions. There's still a lot more that need to
- 10:11Speaker 2: be done. Prevention of vertical integration stuff in the Medicaid space.
- 10:16Speaker 2: So there's still a lot of work on PBM reform.
- 10:19Speaker 2: There is a lot of work on PBM reform to do,
- 10:22Speaker 2: but we have two massive updates that impact us at
- 10:27Speaker 2: a federal and a state level, as well as the FTC.
- 10:32Speaker 2: I cannot wait to share these with you. It's going
- 10:34Speaker 2: to be coming from our friend Greg Ribold, who is
- 10:39Speaker 2: the legal lead for APCI as well as our go
- 10:45Speaker 2: to person for PBM reform. I cannot wait for you
- 10:48Speaker 2: to hear this short interview with Greg to bring us
- 10:51Speaker 2: up to date. But major things happening in the pharmacy
- 10:54Speaker 2: profession this week.
- 10:56Speaker 4: Before we go to Greg.
- 10:59Speaker 2: Ribold rivaled, I do want to give a shout out
- 11:02Speaker 2: to all of those people attending the Pharmacy Profits Summit
- 11:06Speaker 2: live in Dallas, Texas, March twenty eighth through twenty ninth.
- 11:12Speaker 2: Pharmacy Podcast Network will be there. We're going to be
- 11:15Speaker 2: covering this with bells On. I love this conference. I've
- 11:18Speaker 2: gone to every single one of these since the very beginning.
- 11:21Speaker 2: I don't know if this is number six or number seven.
- 11:24Speaker 2: I've been to every single one except for last year
- 11:27Speaker 2: where we had to attend the American Pharmacist Association's annual meeting.
- 11:32Speaker 2: But we are absolutely making this Pharmacy Profit Summit a
- 11:37Speaker 2: heads up to pharmacy owners if you really want to
- 11:39Speaker 2: attend pharmacy conference that digs down into what really is
- 11:45Speaker 2: rubber meets the road and what actually works as pharmacy
- 11:49Speaker 2: owners to increase your revenue. This is the conference you
- 11:53Speaker 2: want to come to. This is the conference that you
- 11:55Speaker 2: want to be a part of and listen to people
- 11:58Speaker 2: when they're speaking that they speak from experience, they speak
- 12:03Speaker 2: from actually getting it done. And the conference is run
- 12:09Speaker 2: and has founded by doctor Lisa Fast, the pharmacy owner
- 12:12Speaker 2: has been a friend of mine for years. She's been
- 12:14Speaker 2: on the Pharmacy fifty list as an influencer because she is.
- 12:18Speaker 2: But she's bringing together some people that really make sense
- 12:21Speaker 2: and I'm excited to be there, excited to dive into
- 12:26Speaker 2: some aspects of business, like Jonathan Adley, who's going to
- 12:30Speaker 2: be talking about the truth on.
- 12:35Speaker 4: AI.
- 12:36Speaker 2: What is true as a pharmacist, what is true as
- 12:40Speaker 2: a pharmacy operator versus some things. There's a lot of
- 12:44Speaker 2: companies out there who will claim they get AI, but
- 12:48Speaker 2: I have to say, just like you might say, hey,
- 12:51Speaker 2: a lot of companies get podcasting right. So you want
- 12:54Speaker 2: a podcast through the pharmacy profession, throughout the pharmacy prefer Russian,
- 13:00Speaker 2: and you want to podcast to the consumer group, and
- 13:04Speaker 2: you want to partner with an organization that thinks the
- 13:08Speaker 2: best of in the highest level of quality of pharmacy
- 13:11Speaker 2: care and pharmacy services.
- 13:14Speaker 4: Why would you work.
- 13:14Speaker 2: With an outside organization that knows nothing about pharmacy, doesn't
- 13:18Speaker 2: have it in their heart.
- 13:19Speaker 4: And that's the way I think of artificial intelligence.
- 13:21Speaker 2: That's the way I think of Jonathan Adley and his
- 13:24Speaker 2: team from.
- 13:26Speaker 4: From TJM Labs and.
- 13:30Speaker 2: Just just the immense amount of attention that's brought to
- 13:33Speaker 2: that you're not gonna want to miss this this episode,
- 13:38Speaker 2: in this interview with t j M Labs CEO Jonathan Adley.
- 13:43Speaker 2: Can't wait for you to hear it coming up here
- 13:45Speaker 2: on twerks and my friend Mike Johnston, CEO of n
- 13:50Speaker 2: p A t NPTA is going to.
- 13:52Speaker 4: Be there talking about the importance of your texts.
- 13:54Speaker 2: Who we just went through the rays of pay for
- 13:58Speaker 2: for Walmart texts and that means that the value of
- 14:01Speaker 2: our Texas absolutely going up. You should be taken care
- 14:04Speaker 2: of that shout out to Stephanie Zimmerman who's going to
- 14:07Speaker 2: be at the Profit Summit Live and she has decades
- 14:11Speaker 2: of leadership in pharmacy business growth. She's gonna have some
- 14:14Speaker 2: strategies in the insurance building secrets PBMs do not want
- 14:19Speaker 2: you to know and just so excited to be a
- 14:23Speaker 2: part of this. So if you are not registered, if
- 14:25Speaker 2: you're not signed up for the Pharmacy Profit summ at Live,
- 14:28Speaker 2: go to Pharmacy Profitsummit live dot com. Once again, that's
- 14:32Speaker 2: Pharmacy Profit Summit live dot com and I will see
- 14:38Speaker 2: you there. And that is for Twerk's News. But be
- 14:42Speaker 2: on lookout. As soon as we come back, we are
- 14:45Speaker 2: gonna give you two major announcements in pharmacy news the
- 14:50Speaker 2: impact the entire profession. You are not gonna want to
- 14:54Speaker 2: miss this.
- 14:55Speaker 5: We'll be right back.
- 14:56Speaker 6: This episode is sponsored by Independent Pharmacy Cooperative, widely known
- 15:00Speaker 6: as IPC. Established in nineteen eighty three, IPC is the
- 15:04Speaker 6: nation's largest group purchasing organization owned by Independent Pharmacy with
- 15:09Speaker 6: a mission of maximizing the success of community pharmacists. IPC
- 15:13Speaker 6: works to provide members with access to effective programs and
- 15:16Speaker 6: services designed to enhance profitability for independent pharmacy. Read more
- 15:21Speaker 6: about our mission by checking out our website at ipcrx
- 15:24Speaker 6: dot com. That's ipcrx dot com.
- 15:38Speaker 3: Hi, I am guaranteeding chief operating Officer with its.
- 15:41Speaker 4: Hey there, welcome to works.
- 15:44Speaker 2: This is our special feature and a returning guest, a
- 15:47Speaker 2: friend of mine, Johnny Kello, CEO of match Rx. Johnny,
- 15:52Speaker 2: it's so good to see you back.
- 15:54Speaker 1: Hey, thanks to thanks for having me again. I'd love
- 15:57Speaker 1: the first two episodes with Alisa Bernstein and Daily talking
- 16:02Speaker 1: about with day at least trump our X and with Elisa,
- 16:06Speaker 1: you know all the things that are DSCSA, you know
- 16:10Speaker 1: that matter and that are coming down the pipeline which
- 16:15Speaker 1: requires even further and further discussion as we near November
- 16:19Speaker 1: twenty twenty twenty six.
- 16:21Speaker 2: Yeah, yeah, two powerful episodes. Our first that featured Matrox
- 16:26Speaker 2: was bringing to the table Elisa Bernstein, one of the
- 16:30Speaker 2: pharmacy fifty most influential people in our in our profession.
- 16:35Speaker 2: Very proud to have had her on talking about DSCSA.
- 16:38Speaker 2: Then we switched gears and we were really digging down
- 16:40Speaker 2: into trump our X and how.
- 16:44Speaker 4: There's just so much unknown right now.
- 16:46Speaker 2: And obviously we just heard about the new federal legislation
- 16:50Speaker 2: being on the desk of President Trump to get that
- 16:53Speaker 2: pushed through. And I'm sure that we can invite back
- 16:57Speaker 2: many of the people that you've recommended, including doctor Daily
- 17:01Speaker 2: pharm D with with his with his team, and and
- 17:05Speaker 2: how deep the knowledge is in these spaces and how
- 17:09Speaker 2: fast things are changing. You know, you started this insights
- 17:14Speaker 2: and started giving us this data and started bringing these
- 17:16Speaker 2: conversations to us Johnny in November, and look how much
- 17:21Speaker 2: has changed in February of twenty twenty six.
- 17:24Speaker 4: Lreaty, It's dynamic.
- 17:27Speaker 1: And today we've got another exciting guest and yes, I
- 17:31Speaker 1: do you know is a farm D runs a group
- 17:37Speaker 1: of independent pharmacies. A lot of excitement and really today's
- 17:42Speaker 1: discussion is going to be revolved around generic compliance ratio.
- 17:46Speaker 1: You know, the GCR that that magic acronym that you
- 17:50Speaker 1: know pharmacies are trying to calculate on a regular basis
- 17:55Speaker 1: isn't always uh, you know, straightforward, and then h having
- 18:01Speaker 1: the right GCR, but also being able to shop outside
- 18:05Speaker 1: of your contract so that you can really make the
- 18:07Speaker 1: difference in the bottom line. So with that, i'd love
- 18:11Speaker 1: to you know, welcome said onto the floor.
- 18:14Speaker 2: Onto the show, Doctor Dana, doctor Dina, Welcome to twerks.
- 18:19Speaker 4: It's good to have you here.
- 18:20Speaker 7: Thank you, thank you. It's an honor of being on here.
- 18:22Speaker 7: Appreciate the warm welcome.
- 18:26Speaker 1: I'm sorry, Todd. So say, look, a lot of farmers
- 18:30Speaker 1: are dispensing, you know, more than ever, but they're keeping
- 18:33Speaker 1: less and you know that as well as anybody. Uh,
- 18:36Speaker 1: But today we want to talk about one of the
- 18:38Speaker 1: quiet metrics behind that. And most farmers get it. But
- 18:43Speaker 1: you know, when you dig down deep, it gets a
- 18:45Speaker 1: little bit more challenging to actually track and calculate. So
- 18:49Speaker 1: I want to, you know, in plain English, I'd love
- 18:51Speaker 1: to hear you under explain to us, you know, the
- 18:55Speaker 1: GCR and policy, but not necessarily theory. How does it
- 19:00Speaker 1: work day to day? Your behavior, your team's behavior, training
- 19:04Speaker 1: your team to understand where they should be buying on
- 19:08Speaker 1: a regular basis. So yeah, perfect.
- 19:13Speaker 4: Yeah, thanks Johnny.
- 19:15Speaker 7: So really GCR, like we said, is the generic compliance ratio,
- 19:20Speaker 7: you know, plan English, it's pretty much what's your percentage
- 19:24Speaker 7: of generic purchasing compared to your brand. You know, let's
- 19:28Speaker 7: say you're getting one hundred thousand dollars in brand purchasing
- 19:31Speaker 7: and you're getting twenty thousand dollars in generics. That puts
- 19:35Speaker 7: you at a twenty percent ratio. Okay, So that's really
- 19:38Speaker 7: kind of the basis of it. And why why is
- 19:41Speaker 7: that important? I would say, just because it allows you
- 19:46Speaker 7: to unlock certain rebate levels with your wholesaler depending on
- 19:53Speaker 7: whatever your contract is. So understanding and knowing where you
- 19:56Speaker 7: stand where a pharmacy stands in GCR is very very important.
- 20:02Speaker 1: Thank you. And I'm going to just back up a
- 20:05Speaker 1: little bit and I'm gonna let Todd kind of give
- 20:09Speaker 1: another intro to said about all his uh you know,
- 20:12Speaker 1: who he is, where he spent his time, what his
- 20:14Speaker 1: specialty is, and Tod, why don't you kind of just
- 20:18Speaker 1: touch on Sayid's you know, background, and why he's sitting
- 20:22Speaker 1: here in front.
- 20:23Speaker 2: Of us, said as a as a pharmacy owner, somebody
- 20:28Speaker 2: that runs a pharmacy and then has layered your experience
- 20:32Speaker 2: to bring on other pharmacies which now challenging and any
- 20:36Speaker 2: growth to now embrace a community specifically, I think that
- 20:40Speaker 2: that that and of itself that could become more books,
- 20:43Speaker 2: more education for some of our new owners. The survival
- 20:47Speaker 2: of independent community pharmacy is really in the hands of
- 20:49Speaker 2: the owners and of the designers of the services you provide.
- 20:53Speaker 2: And you know, you have a background as a director
- 20:55Speaker 2: of operations that's very different necessarily than my realm's just
- 20:59Speaker 2: more about public relations and marketing, even though that can
- 21:03Speaker 2: become part of it, but you really have to pay
- 21:05Speaker 2: attention to the minuscule data. You have to pay attention
- 21:08Speaker 2: to the cost down to the penny, especially with the
- 21:11Speaker 2: temperament and the temperature of the challenges that you're going through.
- 21:15Speaker 2: Expand for our listeners, things that you've done to layer
- 21:18Speaker 2: your experiences has come to this point in being prepared
- 21:22Speaker 2: for scalability.
- 21:23Speaker 4: Yeah, thank you so much.
- 21:25Speaker 8: So.
- 21:25Speaker 7: You know, by trade, I'm a pharmacist, you know, been
- 21:28Speaker 7: a pharmacist for over sixteen years. Most of my time
- 21:32Speaker 7: has really been spent in the management side of multi
- 21:35Speaker 7: unit operations. You know, worked in the chain pharmacies and
- 21:39Speaker 7: then of course in the independent space where I've spent
- 21:42Speaker 7: the majority of my time. I like to help stores
- 21:45Speaker 7: kind of run better day to day, working closely with
- 21:49Speaker 7: owners managers really on workflow, staffing, purchasing and plus margin.
- 21:55Speaker 7: Of course, what really stood out throughout the years is
- 21:59Speaker 7: that you know how small decisions behind the scenes show
- 22:03Speaker 7: up later in the numbers and specifically also with you know,
- 22:06Speaker 7: of course profitability and profitability with GCR. My current role,
- 22:10Speaker 7: you know, like you mentioned directive operation of a group
- 22:13Speaker 7: in independent pharmacies and the Michigan market. A big part
- 22:16Speaker 7: of my job is helping in the daily operation plus profitability.
- 22:21Speaker 7: Drug purchases play a huge role of that, and the
- 22:25Speaker 7: way we buy drugs really influences kind of the end
- 22:30Speaker 7: of the month, how we how our financials look like
- 22:33Speaker 7: and if there's a space for us to kind of
- 22:36Speaker 7: breathe like like I like to say, you know, I've
- 22:39Speaker 7: been I've seen pharmacies really struggle with profitability even having
- 22:45Speaker 7: strong volume, and really simply is because they are not
- 22:50Speaker 7: aligned with their current contracts of purchasing. And the GCR
- 22:54Speaker 7: kind of shows up all over that. So once teams
- 22:57Speaker 7: really understand how purchase behaviors affect their profitability, Uh, you
- 23:03Speaker 7: know the check the picture really changes at that point, right.
- 23:08Speaker 1: Thank you say, that's that's a great overview. And uh
- 23:11Speaker 1: and again, uh, you know, tell us why it's important
- 23:16Speaker 1: and where does this all tie in between your primary
- 23:20Speaker 1: contract buying with your wholesalers and then opportunities to be
- 23:24Speaker 1: outside of your wholesaler to be able to purchase so
- 23:27Speaker 1: that you can have the maximum value on each purchase.
- 23:31Speaker 7: Absolutely, so uh really, GCR everybody has to understand. Every pharmacist,
- 23:38Speaker 7: pharmacy manager, owner has to understand where GCR stands okay
- 23:43Speaker 7: for them to really be able to make a meaningful impact.
- 23:47Speaker 7: And when something that pharmacies don't understand sometimes is when
- 23:52Speaker 7: you're not hitting your GCR, it's affecting the larger picture.
- 23:55Speaker 7: It's not just that rebates on their generics, but also
- 23:58Speaker 7: on the brand names, which we'll.
- 23:59Speaker 4: Talk more about.
- 24:02Speaker 7: When you whenever you maximize your GCR, this is when
- 24:06Speaker 7: from your primary whole saler. This is where it unlocks
- 24:08Speaker 7: the space where you're able to now go shop out
- 24:11Speaker 7: shop from secondary and really drive additional dollars to your
- 24:17Speaker 7: to your margin at that point. But again, it all
- 24:19Speaker 7: ties in with pharmacists and pharmacies understanding what their contracts
- 24:23Speaker 7: are and understanding where they stand on a regular basis
- 24:27Speaker 7: what they're purchasing from their wholesaler.
- 24:31Speaker 1: Right, So tell us what doesn't it measure? Because we
- 24:36Speaker 1: always talk about what it measures. It measures your your
- 24:39Speaker 1: total purchases against your generic purchases. And there's a it's
- 24:43Speaker 1: a sliding scale based on your reimbursement or rather your
- 24:47Speaker 1: rebate from your primary But what doesn't it measure so
- 24:50Speaker 1: that when you do go outside of that, you're not
- 24:53Speaker 1: affecting that GCR. Yeah, so you know when.
- 24:56Speaker 7: You're looking at pharmacies to pharmacies in your comparing them,
- 25:00Speaker 7: it doesn't measure really the financial health directly of a
- 25:04Speaker 7: pharmacy when you compare two together, because each pharmacy might
- 25:07Speaker 7: have a different contract from their wholesaler. So understanding what
- 25:12Speaker 7: truly the contract is, that's what allows you to have
- 25:15Speaker 7: a better understanding of that pharmacy. So you cannot always
- 25:19Speaker 7: compare two pharmacies, Oh, I have twenty percent GCR. Okay,
- 25:23Speaker 7: that doesn't make a difference on the second pharmacy that
- 25:26Speaker 7: has a completely different contract with their wholesaler. So you
- 25:29Speaker 7: have to really understand how it relates to that direct
- 25:33Speaker 7: contract rather than comparing my pharmacy is a twenty five
- 25:37Speaker 7: percent GCR, Well, you know that's fine, it doesn't make
- 25:40Speaker 7: a difference. You have to understand what the contract is first.
- 25:43Speaker 1: So for the more experienced pharmacies that already track their
- 25:49Speaker 1: GC on a regular basis and they're doing exactly what
- 25:52Speaker 1: you're saying, and you know, some of this might be
- 25:55Speaker 1: more of a refresher course for them. Imagine you're talking
- 25:59Speaker 1: to a new pharmacy, somebody who recently out of school,
- 26:03Speaker 1: is working for a pharmacy who wants to improve, or
- 26:07Speaker 1: who recently purchased or opened up a pharmacy. Talk to
- 26:10Speaker 1: them about you know, you know what you'd explain to
- 26:16Speaker 1: the pharmacist who's never thought about it before, or at
- 26:18Speaker 1: least thinks about it, but really doesn't know how to implement.
- 26:21Speaker 1: And that's the key here, I think is that people
- 26:23Speaker 1: know about it, and a lot of the veterans really
- 26:27Speaker 1: understand it. But then there's a segment and some of
- 26:30Speaker 1: the newbies that are in the space who you know,
- 26:32Speaker 1: don't think about it, or if they do, they still
- 26:35Speaker 1: aren't clear on how to apply it on their day
- 26:37Speaker 1: to day business. Very good.
- 26:40Speaker 7: So I explained that GCR again generic compliance Ratio. It's
- 26:45Speaker 7: like your report card with your wholesaler. The wholesaler sets,
- 26:51Speaker 7: you know, expectations around how much you are buying in generics.
- 26:56Speaker 7: Hitting your GCR means you're meeting their expectation, which then
- 27:00Speaker 7: gives you and unlocks different levels of rebate back both
- 27:05Speaker 7: on generics and on brand name, and I'd like to
- 27:08Speaker 7: explain that it's very important to not forget the rebate
- 27:13Speaker 7: that you get on the brands because that really unlocks
- 27:17Speaker 7: a larger dollar amount back into the pharmacy. So this
- 27:22Speaker 7: is very important. One understand what is your contract with
- 27:27Speaker 7: your wholesaler. I hit eighteen percent? What is my rebate
- 27:31Speaker 7: one on generics? And what is my rebate on brands?
- 27:35Speaker 7: I hit twenty percent? How does that look like? And
- 27:38Speaker 7: that's what pharmacies that really manage this process and understand it,
- 27:43Speaker 7: it pays off really well. I'll give you an example
- 27:46Speaker 7: looking at a high volume pharmacy that was consistently and
- 27:50Speaker 7: this is recent was hitting below eighteen percent on their
- 27:55Speaker 7: GCR and they're like, no, we're purchasing all the drugs,
- 28:00Speaker 7: you know, from outside sources.
- 28:02Speaker 4: Okay, no problem.
- 28:04Speaker 7: But what happened is they were missing out two and
- 28:06Speaker 7: a half percent on brand rebates. As soon as they
- 28:10Speaker 7: hit their proper with their contract, they're eighteen percent. In
- 28:13Speaker 7: that specific case, they unlocked ten thousand dollars extra a
- 28:17Speaker 7: month in brand name rebates, which is significant to the
- 28:21Speaker 7: bottom line. But at that point, once they unlock that,
- 28:26Speaker 7: then there's no additional incentives to pushing your GCR from
- 28:31Speaker 7: eighteen to twenty to twenty five percent for example.
- 28:34Speaker 1: Yeah, there's a point of a there's a point of
- 28:36Speaker 1: diminishing returns is what you're saying. Or there's a point
- 28:39Speaker 1: of like there's no added value to having met your GCR.
- 28:43Speaker 1: Once you've met it, recognize it, and then take advantage
- 28:47Speaker 1: of outside sources, you know, to put a you know,
- 28:50Speaker 1: a selfish plug in. You can use matchrx for buying
- 28:53Speaker 1: outside of that, whether it's for generics on their wholesale
- 28:58Speaker 1: side or with other pharmacies. But leave that aside. But
- 29:03Speaker 1: I would say there's a point of diminishing returns or
- 29:07Speaker 1: no return and the generics are where the wholesalers are
- 29:11Speaker 1: making the biggest spreads, so obviously want you to buy
- 29:14Speaker 1: all your generals from them. But once you've met that threshold,
- 29:18Speaker 1: then it's time to really be focused on looking outside
- 29:21Speaker 1: of that. Is that fair.
- 29:22Speaker 7: That you hit it right on? That's exactly what it is,
- 29:25Speaker 7: because as soon as you hit your tier where you're
- 29:28Speaker 7: maxing out your brand, that you leave yourself a little
- 29:31Speaker 7: cushion and then shuffle that additional purchasing from your secondaries okay,
- 29:37Speaker 7: and then you're really unlocking a lot of additional dollars
- 29:41Speaker 7: to your bottom line. There's no point of pushing your
- 29:44Speaker 7: GCR any higher after that. And again this happens with
- 29:50Speaker 7: you know, pharmacies being regularly just used to always buying
- 29:53Speaker 7: everything from one source.
- 29:55Speaker 4: Well, you're losing.
- 29:56Speaker 7: You're leaving a lot of dollars on the table at
- 29:59Speaker 7: that point. So I encourage understanding of your contract and
- 30:03Speaker 7: then knowing when you've hit your you've maxed out your rebates,
- 30:08Speaker 7: and shuffle that dollars.
- 30:09Speaker 1: Okay.
- 30:10Speaker 4: So it's a very important thing.
- 30:11Speaker 1: So talk to us about minimum requirements from the wholesaler
- 30:17Speaker 1: in terms of total volume. Is there a threshold that
- 30:21Speaker 1: needs to be met, say you have to buy three
- 30:25Speaker 1: hundred thousand dollars or whatever the number might be on
- 30:27Speaker 1: a monthly basis for you to even reach a threshold
- 30:31Speaker 1: or is it just purely the ratio that is that matters.
- 30:36Speaker 4: Truth to be told, it depends on the contract.
- 30:38Speaker 1: You know.
- 30:38Speaker 7: Some wholesalers don't have a minimum, some do. I'm working
- 30:42Speaker 7: currently with one great plan, but it's seventy five thousand
- 30:46Speaker 7: dollars in monthly purchased. So when you're you have a
- 30:49Speaker 7: newer pharmacy starting up, it's difficult for you to hit
- 30:53Speaker 7: that seventy five thousand dollars right after the bat, So
- 30:56Speaker 7: then you're not maximizing your rebates for a pharmacy like that.
- 31:00Speaker 7: Truth to be told. I tell them go heavy on
- 31:02Speaker 7: secondary purchasing. Don't don't throw all your dollars to your primary,
- 31:07Speaker 7: because you're never going to maxi on your on your
- 31:11Speaker 7: ratio on your GCR, and you're just giving them extra
- 31:16Speaker 7: dollars that at that point purchase from your secondary. Make
- 31:19Speaker 7: that extra money on there on your bottom line. Now,
- 31:22Speaker 7: when you're start to build up and you're hitting those tiers, no,
- 31:25Speaker 7: bring those dollars back, maximize your GCR, and then relocate.
- 31:31Speaker 7: But that brings us back to understanding having a deep
- 31:33Speaker 7: understanding of what your rate of your contract.
- 31:38Speaker 2: Great, thank you, I have a curve boss, I need So, yeah,
- 31:43Speaker 2: this is something that I'm really interested in. So five
- 31:46Speaker 2: years ago I would not have asked you this because
- 31:49Speaker 2: it didn't exist. Today, we are seeing a trend that's
- 31:54Speaker 2: going to continue to grow in the realm of cost
- 31:57Speaker 2: plus and the realm of cash base. In the realm
- 32:00Speaker 2: of getting completely away. There are pharmacies out there, two
- 32:04Speaker 2: of them in the Pittsburgh area, right in my own hometown,
- 32:08Speaker 2: that do one hundred percent cash base businesses. They're going
- 32:13Speaker 2: to be leaning into clinical services, They're going to be
- 32:15Speaker 2: leaning into other ways of making money. So what you're
- 32:18Speaker 2: describing for our podcast listeners today is relevant because it's
- 32:22Speaker 2: here right now.
- 32:23Speaker 4: This is the business model.
- 32:24Speaker 2: But will this business model continue to transform into something
- 32:30Speaker 2: else where GCR and the overall profitability of our pharmacies,
- 32:35Speaker 2: it will evolve into something different than what we're talking
- 32:39Speaker 2: about today.
- 32:40Speaker 4: Yeah, I think so.
- 32:42Speaker 7: At that point, these pharmacies that are cash plus model
- 32:46Speaker 7: heavily rely on generics. Okay, and at that point, many
- 32:51Speaker 7: of the large wholesalers they wanted your generic purchasing, and
- 32:57Speaker 7: then they give you the brands at a better price
- 32:59Speaker 7: because you're bringing them x amount of volume. If it's
- 33:02Speaker 7: if you're a cost plus model and you don't have
- 33:06Speaker 7: a lot of brand name dispensing, then you're no longer
- 33:10Speaker 7: tied to your primary wholesaler. Those are when I encourage
- 33:14Speaker 7: these pharmacies to go heavy on their secondaries and and
- 33:18Speaker 7: really getting a better rate on their generics. Of course,
- 33:23Speaker 7: they're still going to have brands that they need to dispense,
- 33:26Speaker 7: but dispensing one thousand dollars brand name that you're paying
- 33:30Speaker 7: out of pocket, you're going to see a little bit
- 33:32Speaker 7: less of.
- 33:32Speaker 4: That, in my opinion.
- 33:33Speaker 7: In the cash plus model, it's going to be more
- 33:36Speaker 7: heavier on generics, and true to be told, you know,
- 33:39Speaker 7: there are patients that are on a regular basis with
- 33:43Speaker 7: their insurance, they're overpaying for many generics and the pharmacy,
- 33:48Speaker 7: you know, is not allowed to let the patient know that, hey,
- 33:51Speaker 7: you can get cheaper through your through your cash pay option.
- 33:57Speaker 4: So these models will continue to grow.
- 33:59Speaker 7: And it's interesting to really see where that's going to
- 34:02Speaker 7: navigate you in the next few years.
- 34:05Speaker 1: So is that where you're seeing good pharmacies accidentally hurt themselves.
- 34:11Speaker 7: Yes, So we have pharmacies that at times they don't
- 34:17Speaker 7: understand their contracts and then they're either buying out too
- 34:21Speaker 7: much or they're buying in too much from their wholesaler,
- 34:26Speaker 7: walking in blindly and making purchases blindly just thinking hey,
- 34:30Speaker 7: I'm always getting the good pricing, the best price.
- 34:33Speaker 4: That's not the reality.
- 34:35Speaker 7: You have to kind of micromanage the process, and part
- 34:38Speaker 7: of that is really kind of for the pharmacist to
- 34:41Speaker 7: keep it in the back of their mind always, am
- 34:45Speaker 7: I getting the better price? How does that look like
- 34:47Speaker 7: with my GCR? Where am I with my contract? And
- 34:51Speaker 7: really what is the model of the pharmacy? So is
- 34:54Speaker 7: it a typical open door insurance pharmacy or are we
- 34:58Speaker 7: talking cost plus model?
- 35:01Speaker 3: Great?
- 35:01Speaker 2: Thank you, all right, and then let's take the same data,
- 35:06Speaker 2: let's take the same way of thinking and the coaching
- 35:10Speaker 2: that you're providing on this podcast.
- 35:12Speaker 4: Say it is extremely valuable. Let's add in.
- 35:14Speaker 2: Another slight curve ball, but it's not really that much
- 35:17Speaker 2: of a curveball, because I'm sure that your pharmacies have
- 35:19Speaker 2: been doing this all along anyway. So pharmacies, community pharmacies,
- 35:23Speaker 2: independents are finally getting paid to deliver long term care
- 35:28Speaker 2: pharmacy at home services in a way to actually now
- 35:31Speaker 2: shift and do it from a compliance perspective, actually follow
- 35:36Speaker 2: the formats in order to be reimbursed properly. So when
- 35:40Speaker 2: you start mixing that into the ingredients, now you have
- 35:43Speaker 2: an independent community pharmacy that have almost a little sprinkling
- 35:47Speaker 2: of a couple different models under the same the same roof.
- 35:52Speaker 2: Like one is the straight community retail environment where GCR
- 35:57Speaker 2: plays a big role. An other is me be a
- 36:00Speaker 2: club membership that includes you know, some some clinical stuff
- 36:04Speaker 2: and some services. And then now we have this long
- 36:07Speaker 2: term care pharmacy at home where you get to as
- 36:10Speaker 2: long as you're compliant with long term care standards for
- 36:13Speaker 2: the home based services, you can get reimbursed in a
- 36:16Speaker 2: different way. Talk to us a little bit about that
- 36:18Speaker 2: dynamic too.
- 36:20Speaker 7: Absolutely, long term care at home is exciting and it's
- 36:24Speaker 7: a new thing that we are seeing with the pharmacy reimbursement.
- 36:28Speaker 7: Reimbursement seems to have a little bit of a better
- 36:31Speaker 7: edge on it. So again, you know, we go back
- 36:34Speaker 7: and the bottom line on you know, the insurance is
- 36:38Speaker 7: only going to pay x amount. The next level is
- 36:41Speaker 7: to kind of try to drive the additional profit is
- 36:44Speaker 7: making sure that you know, our pharmacist understand and where
- 36:48Speaker 7: purchasing need to be from really dropping their cost.
- 36:53Speaker 4: Their drug cost.
- 36:55Speaker 7: So that is an exciting thing that we're seeing with
- 36:57Speaker 7: the long term care at home. So we we hope
- 37:00Speaker 7: to continue it. And again, like you mentioned earlier, newer
- 37:06Speaker 7: legislations coming through hopefully you know, empowering pharmacies and providing
- 37:12Speaker 7: more better reimbursement for the independent space. So we're excited
- 37:16Speaker 7: to see what's next.
- 37:19Speaker 1: Say, let's try to simplify this, because you know, we
- 37:23Speaker 1: talk about GCR and managing and monitoring. Could somebody conceivably
- 37:28Speaker 1: just pick a number based on their volume, based on
- 37:31Speaker 1: their purchasing from their wholesaler on a historical basis between
- 37:36Speaker 1: brand Engineeric and say, hey, look, I know that if
- 37:39Speaker 1: I buy ten thousand dollars a month or fifteen thousand
- 37:42Speaker 1: dollars a month outside of my contract with secondaries, then
- 37:47Speaker 1: I feel comfortable that I've met my other requirements in
- 37:52Speaker 1: my contract. Because sometimes people don't want to go through
- 37:56Speaker 1: this entire you know, brain damage, right, And so how
- 38:00Speaker 1: do we simplify it for some farmers to say, hey, look,
- 38:03Speaker 1: pick a number, here's I'm going to buy. I know
- 38:06Speaker 1: I can buy ten, twenty thousand, whatever that number might
- 38:09Speaker 1: be outside of my contract, and I've still met my
- 38:12Speaker 1: obligation and maximized my rebates on my primary. Is that
- 38:16Speaker 1: a kind of a simplified approach to buying outside of
- 38:21Speaker 1: your contract.
- 38:22Speaker 7: A thousand percent, Johnny, If you want to simplify it,
- 38:26Speaker 7: that's probably the easiest and simplest way, Say I have
- 38:30Speaker 7: an X amount, I'm allowed to buy from outside sources secondaries.
- 38:35Speaker 7: Once you hit that, then the remainder of purchases should
- 38:38Speaker 7: be from your primary Okay, that's if you want to,
- 38:41Speaker 7: you know, keep it as simple, no complications to it.
- 38:46Speaker 7: I do encourage, however, always, you know, personally speaking, I
- 38:50Speaker 7: like to see, you know, our screen is green when
- 38:53Speaker 7: we adjudicate a claim that you're properly getting reimbursed. So
- 38:57Speaker 7: I always encouraged saying, you know, take a look at
- 39:00Speaker 7: dispensing and identify drugs that you're regularly losing money on,
- 39:05Speaker 7: and those drugs, for example, you know, estrogen patches, you know,
- 39:09Speaker 7: or birth control commonly come back as negative reimbursement. I
- 39:13Speaker 7: tell pharmacies, you know what, go ahead and make those
- 39:16Speaker 7: a habit that these just automatically goes to your secondary supplier.
- 39:21Speaker 7: Purchases from there get used to reimbursement replenishing from there,
- 39:25Speaker 7: and it just helps you now to keep everything balanced. Yes,
- 39:29Speaker 7: I love your idea of having an X amount kind
- 39:32Speaker 7: of a budget, knowing, hey, don't go over that ten
- 39:35Speaker 7: thousand or fifteen thousand or whatever it might be of
- 39:38Speaker 7: purchasing from outside.
- 39:39Speaker 1: So yeah, yeah, so what you're saying is there's a
- 39:43Speaker 1: double win here. One is a pick a number, bide
- 39:47Speaker 1: outside contract and be pick the products within that amount
- 39:52Speaker 1: of negative reimbursement. So now not only are you getting
- 39:57Speaker 1: the best pricing because you're shopping outside, but also still
- 40:00Speaker 1: not affecting your rebate. So like again a real simple strategy.
- 40:06Speaker 1: Here's the dollar amount, it's five, ten, twenty thirty, whatever
- 40:10Speaker 1: that number might be. And within that amount, pick the items.
- 40:15Speaker 1: Prick the drugs that are primarily a negative reimbursement for you,
- 40:19Speaker 1: so that you're at least either breaking even or making
- 40:22Speaker 1: a little bit and not falling backwards and affecting your
- 40:25Speaker 1: bottom line.
- 40:26Speaker 4: Absolutely, that's a really good way to put it, Johnny,
- 40:29Speaker 4: I like it.
- 40:30Speaker 1: Well, I'm a simple person, so that's why I can
- 40:32Speaker 1: come up with simple ideas. Talk to us about what
- 40:38Speaker 1: really moves the needle for pharmacies. I know you try
- 40:41Speaker 1: to break it out generally into like three buckets, So
- 40:44Speaker 1: tell us a little bit about that, and how do
- 40:47Speaker 1: you approach it regularly again in simplified ways of executing
- 40:52Speaker 1: this plan?
- 40:53Speaker 4: Yeah, absolutely.
- 40:55Speaker 7: First things first, I encourage and every pharmacist manager, pharmacy
- 41:01Speaker 7: owner to understand your your contract with your wholesaler. Okay,
- 41:07Speaker 7: once you understand it, that's number one. Number two is
- 41:09Speaker 7: then kind of just making it part of your daily
- 41:12Speaker 7: behavior with your team, with yourself, is that you're checking
- 41:17Speaker 7: how are you doing.
- 41:18Speaker 4: Overall with your GCR?
- 41:19Speaker 7: Are you going to maximize your primary wholesaler purchases? And
- 41:25Speaker 7: then from there really shop out, go to your secondaries
- 41:30Speaker 7: and take a look. Like we mentioned on your those
- 41:32Speaker 7: negative claims that you're losing money on, move those to
- 41:35Speaker 7: your secondary suppliers, and you really your P and L
- 41:39Speaker 7: will look.
- 41:39Speaker 4: Will really love you.
- 41:40Speaker 7: At that point, you'll see a nice fruitful return on
- 41:45Speaker 7: your bottom line.
- 41:46Speaker 1: So let's like brass tax, right because you know this
- 41:50Speaker 1: sounds great. Okay, I'm a pharmacy. I'm doing you know,
- 41:54Speaker 1: two and a half million dollars a year. If I do,
- 41:59Speaker 1: if I simplify into a plan of buying X, about
- 42:05Speaker 1: how much can I really save under this plan? Is
- 42:08Speaker 1: it a thousand? Is it ten thousand? Is it fifteen
- 42:11Speaker 1: thousand a month? Give us a real so something that's
- 42:14Speaker 1: tangible that people really can sink their teeth into and say, oh,
- 42:18Speaker 1: if I spent this little amount of time to stay
- 42:21Speaker 1: focused and understand, here's the real payoff dollar for dollar
- 42:25Speaker 1: on a two and a half million dollar pharmacy. Just yeah,
- 42:28Speaker 1: I pick that number because it's a relatively average.
- 42:31Speaker 7: Now, so like a pharmacy that you mentioned, two and
- 42:36Speaker 7: a half million can really you know, unlock in depending
- 42:39Speaker 7: on their contract. If let's say they brought in their
- 42:42Speaker 7: brands engineer, purchase it through their primary, they can really
- 42:46Speaker 7: ull lock an additional just depends on their contract two
- 42:49Speaker 7: percent maybe okay of savings on their brands, So extrapolate
- 42:54Speaker 7: that what does that look like? And then as soon
- 42:57Speaker 7: as they maximize their CR, shuffle that additional dollars. I mean,
- 43:03Speaker 7: just the other day, like I mentioned, I had a
- 43:05Speaker 7: pharmacy that you know, could potentially get an additional ten
- 43:08Speaker 7: thousand dollars a month from brand rebate if they properly
- 43:12Speaker 7: structured their purchasing. Another pharmacy was probably ordering an additional
- 43:16Speaker 7: six thousand dollars and monthly generics from their primary, but
- 43:20Speaker 7: they were not receiving any additional GCR. Their top tier
- 43:24Speaker 7: was twenty percent, they were at twenty five percent GCR.
- 43:27Speaker 7: There's no absolutely no reason take that additional six thousand
- 43:31Speaker 7: and purchasing from primary buy it from secondary.
- 43:35Speaker 4: Probably costs.
- 43:35Speaker 7: You you know, four thousand, you've kept an extra couple
- 43:38Speaker 7: thousand in your pocket. So I really encourage kind of
- 43:42Speaker 7: diving deep into those numbers for your pharmacy.
- 43:45Speaker 1: Great, thank you. Yeah, and that's that's tangible. Two thousand
- 43:49Speaker 1: dollars a month, can you know twenty five thousand dollars
- 43:51Speaker 1: a year or even more depending on how aggressive you
- 43:55Speaker 1: want to be and what product types you're buying, you
- 43:58Speaker 1: can save some real dollars that pick a pick where
- 44:02Speaker 1: you want to put it, you know, employees, personal growth
- 44:06Speaker 1: of business, put it in your front end where you're
- 44:09Speaker 1: going to be. You know, you're not tied to rebates
- 44:12Speaker 1: or anything else, and you know we won't. That's a
- 44:14Speaker 1: whole different show talking about the front end. But really,
- 44:17Speaker 1: you know, when you talk about savings, you've got to
- 44:20Speaker 1: pluck throughough places to put it in your kids education,
- 44:23Speaker 1: your wife's new shoes, or your your or your husband's
- 44:29Speaker 1: new you know wallet. But but the bottom line is
- 44:33Speaker 1: that it's it's your money. Recognize that, and you know,
- 44:37Speaker 1: take advantage of what is a simple, uh to follow
- 44:42Speaker 1: tool and really become impactful. So, uh, anyways, I digress
- 44:49Speaker 1: tell us a little bit about the other uh, you
- 44:51Speaker 1: know points that you'd like to keep an eye on,
- 44:54Speaker 1: you know, whether it's your dispensing awareness or your operational habits,
- 44:58Speaker 1: on how you train your team, because it's that about
- 45:01Speaker 1: just doing it yourself. Right. We all know that the
- 45:03Speaker 1: best pharmacies are run by a team, not one person
- 45:07Speaker 1: trying to do everything. That's any business. You know at Matrox,
- 45:10Speaker 1: you know we've got forty people here. I can't do
- 45:14Speaker 1: ninety percent of what my team does. It's or fortunate
- 45:17Speaker 1: enough to have great team members that goes with any business,
- 45:20Speaker 1: including pharmacy. So tell us a little bit about, you know,
- 45:23Speaker 1: how you are actively training your team, following up and
- 45:30Speaker 1: encouraging them to really think like an owner.
- 45:34Speaker 7: Absolutely so really getting them involved. I like to have
- 45:39Speaker 7: everybody involved, you know, in the pharmacy team and understanding why,
- 45:43Speaker 7: like what's the reason behind Okay, you know, really this
- 45:47Speaker 7: drug has to be purchased from this supplier rather than
- 45:50Speaker 7: from primary or primary and vice versa. And having the why,
- 45:54Speaker 7: understanding why behind it. It really allows them to understand
- 45:58Speaker 7: why we're doing this. Another thing is kind of teams
- 46:02Speaker 7: have to understand to be proactive not reactive. A lot
- 46:06Speaker 7: of times they go to order drugs and it's out
- 46:09Speaker 7: of stock. They need to order it, have it and
- 46:12Speaker 7: to buy tomorrow. That way they can have it for
- 46:14Speaker 7: the patient. And a thousand percent understandable. But sometimes you
- 46:17Speaker 7: have to take a look at proactively what are the
- 46:20Speaker 7: medications are is coming up to be filled? Okay, our
- 46:22Speaker 7: ninety day supplies and so on and ahead of time.
- 46:26Speaker 7: If for example, you're doing great in GCR, go ahead
- 46:29Speaker 7: and shop out your secondaries and purchase these drugs. Now
- 46:33Speaker 7: you're fulfilling ahead of time, ordering them ahead of time.
- 46:37Speaker 7: So part of that is again is the habit of
- 46:39Speaker 7: the of the pharmacy team members. Another thing sometimes I see,
- 46:43Speaker 7: you know issues arise is contract pricing change with primary
- 46:47Speaker 7: vendors and the technicians comes or the pharmacy member comes
- 46:52Speaker 7: and immediately just re ordering the exact same NDC. And
- 46:56Speaker 7: that's a big problem because you know, you have to
- 46:58Speaker 7: re substitute depending on your platform, does allowed to automatically
- 47:02Speaker 7: substitute to the preferred generics. You don't want any generic
- 47:06Speaker 7: purchasing that doesn't go towards your overall generic.
- 47:12Speaker 4: Allowance by the.
- 47:14Speaker 7: Wholesaler, because not every generic manufacturer that you can purchase
- 47:19Speaker 7: is going to go towards your GCR. So again, these
- 47:22Speaker 7: are a lot of things that they have to understand
- 47:24Speaker 7: a lot of tidbit as well as understanding the contract.
- 47:27Speaker 7: Sometimes there's some carvat from brands or total purchases. For example,
- 47:32Speaker 7: depending on the contract GLP GP one's medications, some specialty drugs,
- 47:37Speaker 7: drop ship drugs. So having an understanding that you know,
- 47:40Speaker 7: if I'm about to order a two thousand dollars drop
- 47:42Speaker 7: ship item, is this going to count toward my GCR
- 47:46Speaker 7: or not? Okay, a lot of times it does not,
- 47:49Speaker 7: So it gives you a little bit more room. Then
- 47:51Speaker 7: you don't think that you need to move as much
- 47:54Speaker 7: from secondary to primary at that point because you're accounting
- 47:57Speaker 7: for an item that doesn't count against you. So it
- 48:01Speaker 7: all goes back to kind of educating the team, working
- 48:04Speaker 7: with them on a regular basis. And you know, we
- 48:07Speaker 7: really do see pharmacies that are able to turn around
- 48:10Speaker 7: once they get a hangout a handle on their purchasing.
- 48:13Speaker 3: Yeah.
- 48:14Speaker 1: So you know, let's talk about that denominator, that GCR denominator, right,
- 48:18Speaker 1: and it's heavily weighted towards the brands because those are
- 48:21Speaker 1: the most expensive ones, right, you know, does it is
- 48:25Speaker 1: it in the best interest of the pharmacy to buy
- 48:28Speaker 1: sometimes outside of their primary because they don't have a
- 48:32Speaker 1: minimum or they constantly meet their total minimum. But buying
- 48:36Speaker 1: a brand outside of it, whether it's through a secondary
- 48:41Speaker 1: or through a marketplace up because again that continues to
- 48:45Speaker 1: lower that GCR compliance number, because that denominator with the
- 48:51Speaker 1: big ticket item is less, and it gives you more
- 48:53Speaker 1: exposure to being able to buy more generics outside of contract.
- 48:58Speaker 7: Absolutely so, I mean, if you are able to shuffle
- 49:02Speaker 7: some brand name drugs outside to secondary, that's that's a
- 49:06Speaker 7: no brainer there as long as reimbursement on these typically
- 49:10Speaker 7: can be can offset the price of how much you're
- 49:14Speaker 7: purchasing these brands for. If you're getting toward the end
- 49:17Speaker 7: of the month, I always encourage you don't have to
- 49:18Speaker 7: look at your GC on a daily basis. And you know,
- 49:21Speaker 7: especially in the first couple of weeks of the month,
- 49:23Speaker 7: I always say, just you know, it's fine, don't look
- 49:26Speaker 7: at it yet. Have it in the back of your mind,
- 49:28Speaker 7: but don't look at it yet. Once you get to
- 49:30Speaker 7: halfway through the month, stop looking at it. And one
- 49:32Speaker 7: of the things you can do is one bring in
- 49:35Speaker 7: some brand generic purchasing back to primary or two certain
- 49:39Speaker 7: brands if there's space, if there's enough margins spread on them,
- 49:42Speaker 7: take them out, buy them from secondaries, and that goes
- 49:46Speaker 7: away from your total purchasing from your you know, your
- 49:49Speaker 7: formula of how much you're purchasing, and then automatically your
- 49:53Speaker 7: generics is going to look higher your GCR. So that's
- 49:56Speaker 7: another way kind of playing around with that number.
- 49:58Speaker 1: Yeah, yeah, And we see that sometimes in the marketplaces
- 50:02Speaker 1: that we operate in as well as that members will
- 50:05Speaker 1: buy not necessarily just for GCR, just because for the
- 50:07Speaker 1: need of the product where it's not always available from
- 50:11Speaker 1: the primary, but it's the added benefit is that it
- 50:14Speaker 1: lowers their denominator on their GCR numbers.
- 50:18Speaker 7: And to be frank, I mean match is a great
- 50:20Speaker 7: resource for that to getting some of those you know, friend, it's.
- 50:25Speaker 4: True to be told, you know, so I appreciate that.
- 50:28Speaker 1: Thanks, thanks for being the members too. All right, so
- 50:31Speaker 1: tell us because we want to try to start winding
- 50:34Speaker 1: this up, but give us like some fast wins and
- 50:38Speaker 1: and what's one change that feels uncomfortable at first but
- 50:42Speaker 1: pays off. So those are two different questions, but sometimes
- 50:45Speaker 1: they're one and the same.
- 50:47Speaker 7: Well, you know I'm gonna repeat this, but the something
- 50:51Speaker 7: uncomfortable that pharmacies can do first things, it's just calling
- 50:55Speaker 7: their rep for their primary wholesaler and be like, can
- 50:58Speaker 7: you explain to me what my my contract is? You know,
- 51:02Speaker 7: I promise you. You know, majority of pharmacists don't dig
- 51:06Speaker 7: deep into that. So that's the most uncomfortable first thing.
- 51:09Speaker 7: Once you understand it, then you can play with it.
- 51:12Speaker 7: You can, you can really dive into it and push
- 51:16Speaker 7: the numbers and move the needle at that point. So
- 51:19Speaker 7: I encourage you to call your rep. They'll be more
- 51:21Speaker 7: than happy to answer those questions and see you engaged
- 51:24Speaker 7: to learn about it. And then you know, get to
- 51:28Speaker 7: know your numbers. You know, once you do that right away,
- 51:31Speaker 7: you're going to start seeing a big benefit from it.
- 51:35Speaker 1: So and so so like, I don't know about you,
- 51:38Speaker 1: but do you have like a cheat sheet that I
- 51:41Speaker 1: you know, next to your computer that talks about where
- 51:43Speaker 1: those numbers are your threshold or is that between the ears?
- 51:47Speaker 1: Because somebody who's new might say, hey, I understood it,
- 51:50Speaker 1: but I forgot the numbers or you know, I'm not clear,
- 51:54Speaker 1: or it's something you want to share with your team,
- 51:56Speaker 1: tell us a little bit about how you actually, you know,
- 52:00Speaker 1: put it in practice versus just you know, knowing it
- 52:03Speaker 1: because you've been in the business.
- 52:04Speaker 7: Forever personally speaking, you know, I have an Excel calculator
- 52:09Speaker 7: kind of formula I've developed for our plans for our
- 52:14Speaker 7: contracts where we just plug in the numbers and it
- 52:16Speaker 7: kind of gives us a little calculation on how much
- 52:20Speaker 7: is it that we need to how much dollars we
- 52:22Speaker 7: have to move out or move in back to our wholesaler.
- 52:26Speaker 7: So now I don't expect everywhere to do.
- 52:28Speaker 1: That, but.
- 52:31Speaker 7: All your wholesalers, your primary wholesalers, should be sending you
- 52:35Speaker 7: regular communications of what your GCRs are and I would
- 52:41Speaker 7: take that and kind of if you're hitting your GCR
- 52:45Speaker 7: of twenty percent or whatever it might be, then you're good.
- 52:48Speaker 7: Keep a little cushion. Otherwise, you know, reach out and
- 52:52Speaker 7: try and figure that out. I do encourage, you know,
- 52:54Speaker 7: pharmacy owners and pharmacists to you know, develop their own
- 52:58Speaker 7: cheat sheets of that, okay, because that just kind of
- 53:02Speaker 7: lets the team know and themselves kind of an accountability
- 53:06Speaker 7: thing that you know, you're constantly looking at it. So
- 53:10Speaker 7: definitely encouraging to do so.
- 53:13Speaker 1: Right and so so, and they don't have to wait
- 53:15Speaker 1: to do this today. They could or move forward with this.
- 53:19Speaker 1: They could look at their historical twelve month historical and
- 53:23Speaker 1: really based on that information, really determine where they've overbought
- 53:30Speaker 1: from the wholesale of their primary or have maximized their
- 53:35Speaker 1: ratio and been able to maximize their rebates. So you
- 53:39Speaker 1: know what I encourage to you know, folks, is don't
- 53:42Speaker 1: feel like it has to start today. You could start
- 53:45Speaker 1: today and look at your historical and really determine, you know,
- 53:49Speaker 1: your letter, your personal letter grade. Did you do a
- 53:52Speaker 1: really good job of buying, you know and maximizing rebates
- 53:56Speaker 1: and buying outside for extra savings or did you just
- 54:00Speaker 1: hit the rebuy button and the simple like that was easy.
- 54:05Speaker 1: You know, you don't want the easy button all the
- 54:06Speaker 1: time because if you do, I'm betting you that you're
- 54:09Speaker 1: losing opportunity for better pricing outside of your primary.
- 54:15Speaker 4: Absolutely.
- 54:16Speaker 7: And in another thing is if a pharmacy does not
- 54:19Speaker 7: have a secondary, that's that's an easy win. They can
- 54:23Speaker 7: immediately they should sign up for a secondary to start
- 54:26Speaker 7: seeing some savings so not to rely fully on their
- 54:30Speaker 7: primary wholesaler.
- 54:31Speaker 4: So that's also an important thing.
- 54:34Speaker 1: Well, again shameless plug. But they can also sign up
- 54:36Speaker 1: for match our X and look at over a dozen
- 54:38Speaker 1: secondary wholesalers and all in one place.
- 54:41Speaker 4: So absolutely so all right, So, if.
- 54:45Speaker 1: A pharmacy owner only does one thing after hearing this episode,
- 54:49Speaker 1: what should it be?
- 54:51Speaker 4: Yeah, what should it be?
- 54:53Speaker 7: Honestly call your primary rep and understand what their contract is.
- 55:00Speaker 7: As soon as they do that and they understand their contract,
- 55:03Speaker 7: then they can move on the next thing of savings.
- 55:07Speaker 1: So okay, And so I'm going to ask you one
- 55:09Speaker 1: more questions similar, which is the pharmacists who's already done that,
- 55:13Speaker 1: who's the experienced person? Give them something? Because you know,
- 55:18Speaker 1: this is kind of like a roundtable discussion, right I
- 55:21Speaker 1: learned from you, you learn from me. Tell us what
- 55:24Speaker 1: else you would teach or at least worth mentioning, reminding
- 55:28Speaker 1: and experienced pharmacists who already knows his contract, well, what
- 55:34Speaker 1: could they also think about doing that really could help them,
- 55:38Speaker 1: you know, put a few you know, extra dollars in
- 55:41Speaker 1: their pocket on a monthly basis.
- 55:44Speaker 7: What I do see is pharmacies not identifying repeated underwater
- 55:49Speaker 7: claims and really predetermining you know what, you know, you
- 55:55Speaker 7: can have a pharmacy that dispends a lot of a
- 55:57Speaker 7: certain drug because they have a provider right down the
- 56:00Speaker 7: road that refers a lot of patience to them, but
- 56:02Speaker 7: they struggle with that drug identify those buy them from secondary.
- 56:08Speaker 7: It will make a big difference for them for those
- 56:10Speaker 7: experienced pharmacists. And another thing is not to give too
- 56:13Speaker 7: much to the primary at that point. Some of these
- 56:16Speaker 7: experienced pharmacists, you know, they like to get all their
- 56:19Speaker 7: brand rebates, which is great, but then they just leave
- 56:22Speaker 7: too many dollars on the table from their purchasing from
- 56:26Speaker 7: their primary wholesalers. So keep in mind secondary does play
- 56:31Speaker 7: a big role.
- 56:33Speaker 1: Right. Well, that's great, great, two great takeaways. But I
- 56:38Speaker 1: think this episode you really educated.
- 56:42Speaker 7: Me on this.
- 56:43Speaker 1: Yeah, in a lot a lot of ways, And it
- 56:47Speaker 1: feels like there's a couple approaches. One is, you know,
- 56:50Speaker 1: the student that wants to really understand GCR and follow it,
- 56:55Speaker 1: or a simplified approach, which is, here's the fixed dollar out.
- 57:00Speaker 1: I'm buying outside of my contract, buy some things, buy
- 57:03Speaker 1: some brands outside of my contract, and I can not
- 57:08Speaker 1: have to go through the you know, the more detailed way.
- 57:13Speaker 1: So there's more than one way to skin this cat
- 57:16Speaker 1: in saving and maximizing your GCR. Is that fair?
- 57:21Speaker 4: Absolutely well, said Johnny.
- 57:25Speaker 1: Todd. You've been quiet. It's not like you.
- 57:28Speaker 2: No, I'm like you. I was taking notes. I'm learning
- 57:31Speaker 2: something here. I mean, there's there's a lot of good
- 57:33Speaker 2: information in this episode, and say it's it's neat to
- 57:37Speaker 2: see that you've extracted so many years of experience where
- 57:41Speaker 2: you were part of a national chain who understood the
- 57:46Speaker 2: first steps of operation as someone that was supervising. Then
- 57:50Speaker 2: you move up into multiple pharmacies in that independent pharmacy space,
- 57:54Speaker 2: and now you're kind of combining the world of a
- 57:56Speaker 2: buying group as well as with pharmacy into pennant pharmacy
- 58:00Speaker 2: owners and operations. And I think there's a lot of
- 58:03Speaker 2: gold in that. So you're gonna have to promise to
- 58:05Speaker 2: come back on twerks and dig into another subject because
- 58:08Speaker 2: this is this has been great.
- 58:10Speaker 4: Sounds good. Thank you so much. This has been great.
- 58:13Speaker 2: Guys, all right, Shout out to our listeners, Shout out
- 58:16Speaker 2: to our pharmacy technicians, the right hand of our pharmacists
- 58:19Speaker 2: helping us build these businesses. This is not about protecting
- 58:23Speaker 2: your margin and not changing who you are as a pharmacy.
- 58:27Speaker 2: This is about enhancing your profitability. This is about creativity.
- 58:33Speaker 2: You are listening right now, you're coming up with ideas.
- 58:36Speaker 2: If you'd like to share those ideas, if you'd like
- 58:38Speaker 2: to engage with Johnny and in the matt Ars team,
- 58:42Speaker 2: please reach out to Johnny. He's all about getting people
- 58:45Speaker 2: involved in conversations to really change the game and the
- 58:48Speaker 2: profitability and what twenty twenty six has to bring us.
- 58:53Speaker 2: Johnny Kello and the match Arks team, this has been
- 58:56Speaker 2: tremendous and we thank you so much for bringing us
- 58:59Speaker 2: great another great inview here on twerks.
- 59:02Speaker 1: Yeah, thanks Toad. I really enjoyed this one as well. Again,
- 59:06Speaker 1: every one of these it seems like I learned a lot,
- 59:09Speaker 1: not just a few things. But again, I'm not a pharmacist,
- 59:12Speaker 1: so I think that I've got more runway than the
- 59:16Speaker 1: average listener. But I still love hearing these and it
- 59:19Speaker 1: really get really good pointers to pass along to our
- 59:23Speaker 1: members as well.
- 59:24Speaker 2: Hey, if you missed episode one and two, do not worry.
- 59:28Speaker 2: We have a link in the show notes. It'll take
- 59:30Speaker 2: you to all three episodes and it'll make it easy
- 59:33Speaker 2: to access. And if you have any questions, please reach
- 59:37Speaker 2: out to The MATROX team at matcharx dot com can't
- 59:41Speaker 2: wait to see you at a conference out there, Johnny,
- 59:44Speaker 2: Thanks so much, Todd, have a great day.
- 59:51Speaker 6: Feeling lost with the complexities of pharmacy accounting.
- 59:55Speaker 8: In pharmacy today, there's so many different variables and issues
- 1:00:00Speaker 8: that impact the pharmacy, books, records, accounting, the profitabilities, so
- 1:00:04Speaker 8: or so forth. There's different components of pharmacy that have
- 1:00:07Speaker 8: its own nuances from an accounting standpoint, and so it's
- 1:00:10Speaker 8: it's tricky, there's no doubt about it.
- 1:00:12Speaker 6: Ready to take your pharmacy to the next level, but
- 1:00:14Speaker 6: don't know where to start. Psychs and companies here to help,
- 1:00:18Speaker 6: introducing the RX assessment. With the RX Assessment, the pharmacy
- 1:00:23Speaker 6: CPAs and advisors at Psykes will do a deep dive
- 1:00:25Speaker 6: into your accounting and tax situation and give you the
- 1:00:28Speaker 6: action steps you need to take to take your pharmacy
- 1:00:32Speaker 6: to the next level.
- 1:00:33Speaker 8: If you're interested in, you know, working with a team
- 1:00:36Speaker 8: who understands the industry and how the accounting and tax
- 1:00:40Speaker 8: should really be in a pharmacy, this is this is
- 1:00:43Speaker 8: your chance to get an under the hood check of
- 1:00:45Speaker 8: what's going on and getting the feedback of any issues
- 1:00:48Speaker 8: or concerns or again things we think are doing really well.
- 1:00:51Speaker 6: With get the financial check up your pharmacy needs and
- 1:00:54Speaker 6: head over to Sykes HYPHENCPA dot com or call two
- 1:00:57Speaker 6: five to two four eight two seven six four four.
- 1:01:12Speaker 2: Hey, first up on twerks. Welcome back, mister Greg Rivald.
- 1:01:16Speaker 2: It's it's good to have you back on twerks so
- 1:01:19Speaker 2: quickly because I have a lot of questions for you,
- 1:01:21Speaker 2: my friend.
- 1:01:22Speaker 9: Yes, sir, thrilled to be back here. As always a big,
- 1:01:25Speaker 9: big week in pharmacy, so lots lots to talk about.
- 1:01:29Speaker 2: I want you to take over because there's something that's
- 1:01:32Speaker 2: happening at the federal level that impacted PBM reform, there's
- 1:01:36Speaker 2: something at the FTC level that now impacts the profession
- 1:01:40Speaker 2: and pharmacy as well.
- 1:01:42Speaker 10: Break those two down for.
- 1:01:43Speaker 3: Me, yeah, for us, Yeah, I promise you I will
- 1:01:47Speaker 3: do my best.
- 1:01:48Speaker 1: Right.
- 1:01:48Speaker 9: There's there's so much to you know, really so much
- 1:01:51Speaker 9: to unpack here. But what I would say, big picture,
- 1:01:55Speaker 9: one of the biggest weeks we've seen, probably the biggest
- 1:01:58Speaker 9: week we've seen federally in pharmacy. And I don't I
- 1:02:02Speaker 9: don't want to be bombastic here, right, but I think
- 1:02:05Speaker 9: that that's accurate to say at this point. What we
- 1:02:09Speaker 9: saw this week is as part of the large reconciliation
- 1:02:14Speaker 9: budget bill, you know, there were significant PPM reform provisions
- 1:02:19Speaker 9: included within that, right and a lot of these provisions
- 1:02:22Speaker 9: are core provisions from pharmacy's own Congressman Buddy Carter's bill
- 1:02:27Speaker 9: that he had and also consistent with what was so
- 1:02:31Speaker 9: heartbreaking for so many folks back in twenty twenty four,
- 1:02:35Speaker 9: you know, as it was getting ready to be included
- 1:02:37Speaker 9: in the year end package, and then there was a
- 1:02:39Speaker 9: sort of a tweet that shall go unnamed that sort
- 1:02:42Speaker 9: of unraveled all of that, Right, and so we're in
- 1:02:45Speaker 9: a position now where we are seeing probably not probably,
- 1:02:49Speaker 9: we're seeing the strongest, most meaningful PBM reforms ever implemented
- 1:02:54Speaker 9: and signed into law. Right, so passed and signed into
- 1:02:56Speaker 9: the law this week. I would say, in broad stroke,
- 1:03:00Speaker 9: what you'll see here is that, you know, in the
- 1:03:03Speaker 9: part D space, you've got sort of this D linking concept,
- 1:03:07Speaker 9: which is, hey, PBMs, you can be paid a bona
- 1:03:10Speaker 9: fide service fee, but you know you can't make money
- 1:03:13Speaker 9: off the price of a drug, right, so powerful concept.
- 1:03:16Speaker 9: There's a lot of technicalities there and a lot of
- 1:03:19Speaker 9: I would say nuance that has to be worked through.
- 1:03:22Speaker 9: But conceptually, hey, PBMs, you can't exploit the price of
- 1:03:26Speaker 9: a drugrug. Pretty powerful concept to get into law.
- 1:03:29Speaker 5: Right.
- 1:03:30Speaker 9: In terms of pharmacy reimbursement, you've got these reasonable and
- 1:03:33Speaker 9: relevant requirements that calls on CMS to promaate regulations to
- 1:03:38Speaker 9: ensure pharmacies are getting reasonable and relevant reimbursements, as well
- 1:03:42Speaker 9: as treating some sort of certain pharmacies a little bit
- 1:03:46Speaker 9: different to kind of protect them based on size or
- 1:03:48Speaker 9: area and so. And then there's I would say, really
- 1:03:51Speaker 9: significant reporting requirements as well. So this is I think
- 1:03:56Speaker 9: it's very important to say, like, this is not the end, right,
- 1:03:58Speaker 9: I think this is the important thing is that he
- 1:04:00Speaker 9: is this going to be a catalyst to more reforms
- 1:04:04Speaker 9: to protect patients, more reforms to ensure the sustainability of pharmacy.
- 1:04:08Speaker 9: I hope very much so that that's the case. But
- 1:04:10Speaker 9: this is a significant, significant victory. You know, a lot
- 1:04:14Speaker 9: of folks have worked really hard on this. Frankly, I'm
- 1:04:17Speaker 9: probably not the best person to be sitting here talking
- 1:04:19Speaker 9: about it, right because I would say, you've got I mean, boy,
- 1:04:24Speaker 9: you get philosophical, and I think of like Doug Collins, right,
- 1:04:26Speaker 9: who's in the President Trump's cabinet now, and he was
- 1:04:29Speaker 9: a leader on PBM reform, you know, going back in
- 1:04:32Speaker 9: you know, the early twenty tens. And obviously Congressman Buddy
- 1:04:36Speaker 9: Carter has worked so hard on this his you know,
- 1:04:40Speaker 9: his staff, Jack Gander, they've worked so hard. In NCPA
- 1:04:43Speaker 9: has worked really hard on this reform as well. So
- 1:04:46Speaker 9: I think it's a hopefully a special moment for pharmacy,
- 1:04:50Speaker 9: I would add, you know, from a policy perspective, I
- 1:04:52Speaker 9: think there's a lot of work to do to protect
- 1:04:54Speaker 9: pharmacists and will of course be working to hopefully advance
- 1:04:58Speaker 9: pharmacists fight back in that regard, but this is a
- 1:05:01Speaker 9: moment that hopefully pharmacy should saber and the folks who've
- 1:05:04Speaker 9: worked so hard on it. So on top of that, right,
- 1:05:09Speaker 9: like as though that wasn't enough, we saw a major
- 1:05:13Speaker 9: settlement come out with the.
- 1:05:14Speaker 3: FTC and Express Scripts, Right, Obviously, the FTC has been
- 1:05:17Speaker 3: doing ongoing work.
- 1:05:19Speaker 9: In connection with PBMs and a six piece study, and
- 1:05:25Speaker 9: you know, they brought actions against the Big three PBM
- 1:05:28Speaker 9: and connection with high insulin prices, and what you see
- 1:05:32Speaker 9: is really some fascinating some fascinating things that are coming
- 1:05:36Speaker 9: out of that. You know, APCI, who I work with,
- 1:05:39Speaker 9: has been a long time proponent of the Section five
- 1:05:43Speaker 9: of the FTC Act, which is unfair methods of competition
- 1:05:47Speaker 9: and really believing that a lot of PBM practices fall
- 1:05:50Speaker 9: into that unfair methods of competition, and you know, it's
- 1:05:54Speaker 9: something we've certainly been hopeful to see.
- 1:05:56Speaker 3: The FTC utilize.
- 1:05:58Speaker 9: And so, you know, from it's kind of right, but
- 1:06:00Speaker 9: from my perspective, it was really exciting to see that
- 1:06:03Speaker 9: sort of serve as a basis for you know, really
- 1:06:06Speaker 9: a lot of what the FTC was doing there. And again,
- 1:06:09Speaker 9: a lot of folks in the community pharmacy space have
- 1:06:12Speaker 9: worked really hard to engage with the FTC. The FTC
- 1:06:15Speaker 9: team has worked really hard and continues to work hard,
- 1:06:19Speaker 9: and so just so encouraging. There are a lot of
- 1:06:23Speaker 9: really good, interesting things within this settlement, you know, perfect no, right,
- 1:06:27Speaker 9: there's I think there's a lot of nuance and we're
- 1:06:29Speaker 9: still unpacking a lot of that nuance.
- 1:06:31Speaker 3: Maybe, you know, maybe.
- 1:06:32Speaker 9: We can discuss that, Todd, you and I on the
- 1:06:34Speaker 9: PBM Reform podcast or some other some other forum. But
- 1:06:38Speaker 9: it's a big deal, right, You got the you got
- 1:06:43Speaker 9: you could argue, right, yes, I waving the white flag
- 1:06:45Speaker 9: here and resolving these allegations and agreeing to behavior or
- 1:06:51Speaker 9: agreeing to practices that is going to hopefully curb some
- 1:06:55Speaker 9: of the more unfair practices we see implemented by large ppms.
- 1:07:00Speaker 2: More and more is taking place to really make the
- 1:07:04Speaker 2: long lasting changes that we've all known had to be
- 1:07:08Speaker 2: made of simple things like if you're an insurance company,
- 1:07:12Speaker 2: you can own a pharmacy because it's just too much
- 1:07:15Speaker 2: intertwining of rates of services and reimbursement and patient steering
- 1:07:24Speaker 2: and so it's just like it's just bad business. And
- 1:07:27Speaker 2: we saw it happen. I know the majority of our
- 1:07:30Speaker 2: listeners probably don't remember this, but the divestiture of the
- 1:07:34Speaker 2: Baby Bells and Learning, you know, our AT and T
- 1:07:38Speaker 2: into seven separate organizations because telecommunications was being rained by
- 1:07:43Speaker 2: one organization, and the government the FTC is like, hey,
- 1:07:48Speaker 2: this is dangerous for the telephone and telecommunication infrastructure of
- 1:07:56Speaker 2: our nation. We cannot allow one organization to have that
- 1:08:00Speaker 2: much power over its people. Well, guess what you're saying
- 1:08:04Speaker 2: the same damn thing, but with people's health.
- 1:08:07Speaker 10: You're saying the.
- 1:08:07Speaker 2: Health of the nation cannot be controlled by three bohemoth
- 1:08:13Speaker 2: PBMs who are literally in some ways killing people. I mean,
- 1:08:18Speaker 2: there are people that have died because of PBM policies.
- 1:08:22Speaker 10: They might not have attended that to.
- 1:08:23Speaker 2: Happen, but it's the domino effect of things that have
- 1:08:26Speaker 2: happened that I think of Bill Schmidtnick and his family.
- 1:08:29Speaker 2: Then you and I have spent lots of time with
- 1:08:31Speaker 2: Bill and his family. And this is what the truth
- 1:08:34Speaker 2: that's coming out. It's and by the way, it's black
- 1:08:36Speaker 2: and white data. It's not any embellishing, we're not hyperboil.
- 1:08:40Speaker 2: We're like, we really want actually I want PBMs to
- 1:08:43Speaker 2: do what they originally did. They were wonderful and it
- 1:08:46Speaker 2: really made things simple and you know, access to formula
- 1:08:49Speaker 2: y information and it was great.
- 1:08:51Speaker 10: Well, go back to the value that you bring.
- 1:08:54Speaker 2: And I don't have to tell you this, but you
- 1:08:57Speaker 2: and I know that it's never going back to the
- 1:08:58Speaker 2: way it was.
- 1:08:59Speaker 10: It's it's from this point forward. It's it's really changing.
- 1:09:04Speaker 5: It is it is.
- 1:09:04Speaker 9: And listen, I think if you're behind the pharmacy counter,
- 1:09:08Speaker 9: the way it feels like when is helped going to
- 1:09:09Speaker 9: come right, and we've seen but when you look at
- 1:09:12Speaker 9: sort of in the aggregate the work that's been done
- 1:09:15Speaker 9: in states, and now you see like real reform happening
- 1:09:18Speaker 9: at the federal level. I'm a broken record on this, Todd,
- 1:09:22Speaker 9: but you know, it is hard to pass a bill right.
- 1:09:25Speaker 9: And you know, there are so many organizations, so many
- 1:09:27Speaker 9: professions that advocate forever and never make any progress right,
- 1:09:32Speaker 9: and we're go, you know, this advocacy attempts are being
- 1:09:36Speaker 9: made to reform the practices of amongst the biggest companies
- 1:09:40Speaker 9: on Earth, amongst the richest companies on Earth, you know,
- 1:09:43Speaker 9: with armies of lobbyists, and so to see the reforms
- 1:09:46Speaker 9: that are happening at the state level, at the pace
- 1:09:48Speaker 9: that they're happening, and to see you know, meaningful reform
- 1:09:52Speaker 9: happening at the federal level, and to see the action
- 1:09:55Speaker 9: that the FTC has taken, I think it's a good boy.
- 1:09:58Speaker 9: You know, Friday afternoon, it's a good time to take
- 1:10:00Speaker 9: a step back and reflect a little bit about how
- 1:10:03Speaker 9: far the advocacy fight has come. And does does that
- 1:10:07Speaker 9: mean the work is over? Absolutely not. I would argue
- 1:10:09Speaker 9: it's you know, it's time to really now, it's time
- 1:10:12Speaker 9: to roll back up the enjoy this weekend and then
- 1:10:14Speaker 9: it's time to get to work because there's.
- 1:10:16Speaker 3: A lot more work to do.
- 1:10:17Speaker 9: But there's a lot for pharmacy to be proud of,
- 1:10:19Speaker 9: a lot for you know, community pharmacists to be proud of.
- 1:10:23Speaker 3: And again, you know, I think.
- 1:10:24Speaker 9: Kudos to Congressman Buddy Carter at NCPA on this. Who've
- 1:10:30Speaker 9: you know who've worked on this issue for a long time.
- 1:10:32Speaker 2: Absolutely absolutely just to shout out to all of them,
- 1:10:36Speaker 2: many of them I've been able to meet in person
- 1:10:38Speaker 2: and see the passion in their eyes and and how
- 1:10:41Speaker 2: it attributes back to you know, Buddy was a pharmacist
- 1:10:45Speaker 2: in his community and a pharmacy owner and he saw
- 1:10:48Speaker 2: it firsthand of what it did to not only his
- 1:10:50Speaker 2: own business and livelihood, but with the impact that it had.
- 1:10:53Speaker 10: On his community, and he hated it.
- 1:10:55Speaker 2: He was you know, he told me that's part of
- 1:10:58Speaker 2: the reason now he sees he sees being a state
- 1:11:01Speaker 2: representative from so many different angles, and he has a
- 1:11:07Speaker 2: lot of expertise and things that he's not an expert
- 1:11:10Speaker 2: in that he can really leverage.
- 1:11:12Speaker 4: So yeah, that's awesome.
- 1:11:14Speaker 3: It is.
- 1:11:14Speaker 9: And again, like you know, no time to list everybody,
- 1:11:17Speaker 9: but when you just look in the agg or get
- 1:11:19Speaker 9: obviously you know comes from the Harsh Barger and James Comer,
- 1:11:23Speaker 9: you know, and the hearings Chairman of Oversight, right. I mean,
- 1:11:27Speaker 9: there's so many and Senate Finance has done amazing we can't.
- 1:11:31Speaker 3: Name them all.
- 1:11:32Speaker 9: But it's again, I think it's a good time late,
- 1:11:35Speaker 9: you know, Friday afternoon, it's a good time for folks
- 1:11:37Speaker 9: to reflect. Don wow, like, when when have we ever
- 1:11:40Speaker 9: seen this much federal activity on this issue? And it's
- 1:11:44Speaker 9: you know, it's significant, and I hope from a policy perspective,
- 1:11:48Speaker 9: and we'll be having more policy conversations on PBM Reform
- 1:11:51Speaker 9: Podcast and doing deep dives right because you know, there
- 1:11:55Speaker 9: there's work to do, and so my hope is that
- 1:11:57Speaker 9: this is very much. Hey, we appreciate the work that's
- 1:11:59Speaker 9: been done and hope this is a catalyst for more
- 1:12:03Speaker 9: good work to come.
- 1:12:05Speaker 2: I tell you what, Greg gets so good to have
- 1:12:07Speaker 2: you give us this update. He really makes it more
- 1:12:10Speaker 2: simplified and understand it. I am excited that we're going
- 1:12:16Speaker 2: to continue the PBM Reform Podcast. If you're listening, if
- 1:12:21Speaker 2: you have a state representative that you know it wants
- 1:12:25Speaker 2: to talk with Greg, that wants to get involved, that
- 1:12:28Speaker 2: wants to continue to refine this from that state perspective
- 1:12:32Speaker 2: as well as what's going to happen at the federal level.
- 1:12:35Speaker 10: Reach out to Greg. He's a huge resource.
- 1:12:39Speaker 2: Thank you so much, APCI for your support of the
- 1:12:44Speaker 2: PBM Reform podcast. We're actually making so many more connections now,
- 1:12:49Speaker 2: especially through like LinkedIn and in Instagram, or we're getting
- 1:12:53Speaker 2: new listeners listening to this podcast where they are getting
- 1:12:57Speaker 2: feedback where they're saying, wow, I can listen to updates
- 1:13:00Speaker 2: on things that I didn't understand what that meant. And
- 1:13:03Speaker 2: now we have someone that is either a pharmacy owner
- 1:13:06Speaker 2: or a state representative or somebody like you, Greg who's
- 1:13:09Speaker 2: in the thick of it.
- 1:13:10Speaker 10: So thank you so much for giving us an update.
- 1:13:14Speaker 9: Now, thank you, And yeah, I'm going to give you
- 1:13:16Speaker 9: a real quick shout out here because you know, on
- 1:13:19Speaker 9: the Pharmacy Podcast Network, right, I mean, you've been a
- 1:13:22Speaker 9: magnifying voice of issues for pharmacists across the spectrum, right,
- 1:13:26Speaker 9: not just on PBM reform, but that said, you were
- 1:13:29Speaker 9: calling attention to PBM reform before it was cool as
- 1:13:33Speaker 9: they say, right, And so I hope, I hope that
- 1:13:36Speaker 9: you're taking some satisfaction here on a Friday afternoon as well.
- 1:13:40Speaker 10: Absolutely.
- 1:13:41Speaker 2: Hey, And speaking of this, this is the most important
- 1:13:44Speaker 2: question I asked this. I mean, I ask this of
- 1:13:47Speaker 2: our other guests on twerks today. But is it is
- 1:13:50Speaker 2: it Patriots or is it the Seattle Seahawks?
- 1:13:54Speaker 9: Oh, Lauren, I bet you're gonna have to stay neutral
- 1:13:57Speaker 9: on that one. But you know I'd say this, right. Uh,
- 1:14:00Speaker 9: Seattle didn't have the have the trophies the Patriots do,
- 1:14:03Speaker 9: so we'll go with them.
- 1:14:06Speaker 2: Yeah, I'm gonna go with the Seahawks because I do
- 1:14:09Speaker 2: not want the Patriots to have more Super Bowls than
- 1:14:12Speaker 2: the Pittsburgh Steelers.
- 1:14:14Speaker 3: Yeah, they've got enough, Right, They've got enough.
- 1:14:17Speaker 2: All right, Greg, Thanks for being a guest on twerks. Hey, listen, listeners,
- 1:14:21Speaker 2: We're going to be right back. Hey, welcome back to
- 1:14:39Speaker 2: this Week in Pharmacy. Thanks for staying and being part
- 1:14:44Speaker 2: of this. The feedback that we get through LinkedIn, the
- 1:14:48Speaker 2: feedback that we're getting on our YouTube channel, you're asking
- 1:14:52Speaker 2: a lot of great questions. This is a shout out
- 1:14:55Speaker 2: to you too, the listener. If there's a subject that's
- 1:14:58Speaker 2: that's impacting our profession, and if it's education, artificial intelligence,
- 1:15:03Speaker 2: long term care, clinical trial, bringing clinical trials closer to community.
- 1:15:09Speaker 2: There's a lot happening and things are speeding up. You
- 1:15:14Speaker 2: did hear me mention artificial intelligence, and I think we're
- 1:15:20Speaker 2: doing six episodes per week, five six episodes per week,
- 1:15:23Speaker 2: and it's up to like two potentially three episodes per
- 1:15:28Speaker 2: week that will include how important it is to understand
- 1:15:32Speaker 2: the end leverage properly evidence based technologies into our specific
- 1:15:39Speaker 2: sectors of pharmacy. And there's a group out there that
- 1:15:43Speaker 2: is really coming heavy into different sectors of pharmacy. And
- 1:15:48Speaker 2: we're going to be doing some additional deep dive podcasts.
- 1:15:52Speaker 2: We're going to invite other organizations out there who are
- 1:15:56Speaker 2: as dedicated as this team is. I'd like to welcome
- 1:16:00Speaker 2: Jonathan Adley from TJM Labs to Twerks.
- 1:16:05Speaker 11: Welcome to Twerks, buddy, Thanks Dott, I'm super excited to
- 1:16:09Speaker 11: be here.
- 1:16:10Speaker 4: All right. I'm telling you what.
- 1:16:14Speaker 2: As fast as the profession is changing, as fast as
- 1:16:17Speaker 2: our pharmacist's roles are changing, and how they're going to
- 1:16:20Speaker 2: start digging deep into clinical navigation, of treatment management and
- 1:16:25Speaker 2: of suggestion and of really becoming closer to the patient
- 1:16:30Speaker 2: and having the ability to leverage pharmacogenomics data and having
- 1:16:33Speaker 2: the ability to dive down into you know, in vitro
- 1:16:39Speaker 2: fertilization and contraception, and there's so many there's so many
- 1:16:43Speaker 2: verticals right now, Jonathan, to empower pharmacists. And now you
- 1:16:49Speaker 2: guys are coming very intimately into the pharmacy space by
- 1:16:54Speaker 2: so many of your partnerships based in the pharmacy profession.
- 1:16:58Speaker 2: This is like two things CALLI at the same time.
- 1:17:01Speaker 2: The role of the pharmacy is changing, and now TJM
- 1:17:05Speaker 2: Labs comes into the picture to accelerate that based on
- 1:17:08Speaker 2: some trust of what you've already built in infrastructure. So
- 1:17:13Speaker 2: kick us off, tell us quickly, because I have other
- 1:17:16Speaker 2: questions for you.
- 1:17:18Speaker 4: Who is TJM Labs. What do you guys do?
- 1:17:21Speaker 5: Awesome?
- 1:17:21Speaker 11: Awesome, So TJM Labs we are workflow pharmacy automation company,
- 1:17:28Speaker 11: specifically AI automation. There is some old fashioned automation and
- 1:17:32Speaker 11: there is newer kind of automation that is AI based.
- 1:17:36Speaker 11: The thing that we do is essentially automate. The core
- 1:17:40Speaker 11: product that we offer is automate data entry. So if
- 1:17:42Speaker 11: you think about facts is coming through the pharmacy, E
- 1:17:45Speaker 11: prescription refills some of our long term companies they do
- 1:17:51Speaker 11: like mid trick, some of them they do chart review
- 1:17:55Speaker 11: all of this stuff. These spots can do it right,
- 1:17:58Speaker 11: and we like to exciply in these spots as a
- 1:18:01Speaker 11: digital technician, which is able to work twenty four to seven,
- 1:18:06Speaker 11: you know, a NonStop and depending any pharmacy management system
- 1:18:10Speaker 11: and a complexity. Sometimes it works a little bit faster,
- 1:18:12Speaker 11: sometimes it's a little bit slower.
- 1:18:14Speaker 4: Yeah, there's always adjustments.
- 1:18:15Speaker 11: There's always adjustment, but it is pharmacy specific. I am
- 1:18:19Speaker 11: a pharmacist, right Meghan, Our chief operating officer is a pharmacist,
- 1:18:24Speaker 11: and we basically the company is built for by pharmacist
- 1:18:28Speaker 11: for pharmacies with I would say, a lot of domain
- 1:18:31Speaker 11: expertise in Pacific pharmacy workflows.
- 1:18:35Speaker 2: That's blowing my mind and getting me excited because, like
- 1:18:39Speaker 2: I said in the opening, pharmacists are now going to
- 1:18:45Speaker 2: become leaders in disease state management, best best care practices,
- 1:18:51Speaker 2: personalized medicine, and experience.
- 1:18:54Speaker 4: Neutral genomics is part of this.
- 1:18:55Speaker 2: Where a cancer patient that's suffering, you know, maybe their
- 1:19:00Speaker 2: first chemotherapy experience, they feel crappy, and then all of
- 1:19:05Speaker 2: a sudden, the pharmacist is really helping to minimize that
- 1:19:08Speaker 2: as much as possible with nutrition or vitamins or whatever
- 1:19:13Speaker 2: goes along with the medications.
- 1:19:15Speaker 4: That's special. And if we had an AI engine to.
- 1:19:19Speaker 2: Start collecting information like the patient's response based and app
- 1:19:24Speaker 2: that you give them, or how they're feeling down to
- 1:19:26Speaker 2: the one through ten scale or anything that you can
- 1:19:30Speaker 2: personalize and even use gamification to get their response, if
- 1:19:35Speaker 2: you could funnel that into an AI engine, and I'll
- 1:19:38Speaker 2: back then into our pharmacy management systems to really respond
- 1:19:41Speaker 2: from two sides, process and getting the prescription out as
- 1:19:45Speaker 2: safely as possible, which is the commitment obviously of the
- 1:19:50Speaker 2: groundwork of pharmacists, but the more important side is reacting
- 1:19:55Speaker 2: to clinical information, journal articles and the response from the
- 1:20:00Speaker 2: patient of how things are going in a specific segment
- 1:20:04Speaker 2: of treatment. And then now have having your lab organization
- 1:20:09Speaker 2: infuse and react. I mean, that's the future of you know,
- 1:20:13Speaker 2: pharmacy care in my opinion.
- 1:20:16Speaker 11: Yeah, I mean, we always say that AI agents are
- 1:20:19Speaker 11: meant for tedious work. Let AI do the tedious work
- 1:20:23Speaker 11: and let humans do the personal and warm touch. So
- 1:20:26Speaker 11: if you think about it, you know, typically we all
- 1:20:29Speaker 11: have worked in a pharmacy before six.
- 1:20:31Speaker 5: Out of the eight hours we spend in there, if.
- 1:20:33Speaker 11: You're lucky, are just tedious work. You're literally sitting on
- 1:20:36Speaker 11: a screen, heading the keyboard and clicking the mass with
- 1:20:40Speaker 11: very little judgment and nuance.
- 1:20:43Speaker 5: And in two.
- 1:20:43Speaker 11: Hours, could be consulting, could be vision care, could be
- 1:20:46Speaker 11: truly intellectual activities, and we say, well, you don't have
- 1:20:51Speaker 11: to do the TDA stuff anymore. Right, it could be
- 1:20:54Speaker 11: all it could be all bevis care, and then we'll
- 1:20:57Speaker 11: have the AI do all the tedos stuff.
- 1:21:01Speaker 2: Hey, so our common friend Ross on your team gave
- 1:21:04Speaker 2: me a shout out on LinkedIn, and I like how
- 1:21:08Speaker 2: interactive your team is on LinkedIn because that's still a
- 1:21:12Speaker 2: platform that I see a big differentiation between Facebook and
- 1:21:17Speaker 2: other platforms that are more consumer driven. I trust my
- 1:21:21Speaker 2: LinkedIn network, like everybody that's in my network is like
- 1:21:25Speaker 2: the real deal, and every time they talk about something,
- 1:21:28Speaker 2: it's like I'm getting it from the source. Like, as
- 1:21:31Speaker 2: a publisher, it's a dream and I love this. So
- 1:21:34Speaker 2: in this AI space, you're mixed into pharmacy already. Your
- 1:21:38Speaker 2: client base is freaking amazing. Will put a link into
- 1:21:43Speaker 2: some of the things you guys have worked on. But
- 1:21:45Speaker 2: you're releasing a book that's really going to help us
- 1:21:48Speaker 2: dial into and getting more out of thinking about how
- 1:21:52Speaker 2: should AI impact the business that I am running as
- 1:21:57Speaker 2: a pharmacist in order for me to assure that I'm
- 1:22:00Speaker 2: developing developing the best treatment for my patients and my
- 1:22:06Speaker 2: families of my patients, but then turn around and being
- 1:22:09Speaker 2: able to operationalize my reporting and my staffing and my
- 1:22:15Speaker 2: I mean, this is like I said, it's it's two
- 1:22:18Speaker 2: things coming together. Would you give the listeners a kind
- 1:22:21Speaker 2: of a quick overview of your book? And we got
- 1:22:24Speaker 2: we got to get our hands on it, so let
- 1:22:26Speaker 2: us know how to get our hands on it too.
- 1:22:28Speaker 11: Yeah, So we wrote this book just to let the
- 1:22:31Speaker 11: audience know we really wrote it for one simple reason.
- 1:22:33Speaker 11: We want to help pharmacy succeed. Our company gets bigger
- 1:22:37Speaker 11: when our pharmacies succeed. It's as simple as that. And
- 1:22:40Speaker 11: if you look on the surface at least, the pharmacy
- 1:22:42Speaker 11: business is really tough right now. I don't know, it's
- 1:22:45Speaker 11: not a long ago and write eight one bankrupt and
- 1:22:48Speaker 11: right after it, Walt Green's was taken by Brevet Private
- 1:22:51Speaker 11: Equity and they said publicly they're going to break it
- 1:22:53Speaker 11: into pieces and sell it.
- 1:22:55Speaker 5: Everybody knows how.
- 1:22:55Speaker 11: Bbm's kind of routinely reimpurse pharmacies blow cost labor expenses
- 1:23:01Speaker 11: with inflation just continue to rise and rise, so your
- 1:23:05Speaker 11: costs are getting higher and higher if you run a pharmacy,
- 1:23:08Speaker 11: and you're not getting any additional revenue. So if you're
- 1:23:11Speaker 11: sitting there, it could feel like it's impossible to get ahead, right,
- 1:23:15Speaker 11: but it's not. We're so lucky in our companies that
- 1:23:19Speaker 11: because we work with hundreds of pharmacies and we're not
- 1:23:22Speaker 11: just like a tick vendor where we don't interact with them.
- 1:23:25Speaker 11: It's a partnership. We see their businesses, we see what
- 1:23:27Speaker 11: makes them successful. We over the last two years, we
- 1:23:32Speaker 11: saw a few things that pharmacies can do that essentially
- 1:23:36Speaker 11: make them stand out and make them you know, eight
- 1:23:39Speaker 11: figure pharmacies as we like to call it, right, and
- 1:23:42Speaker 11: the eight figure is one hundred million, So you know
- 1:23:45Speaker 11: that's basically can you run a pharmacy and get it
- 1:23:48Speaker 11: one hundred million?
- 1:23:49Speaker 5: And what would it take to do that? And we
- 1:23:52Speaker 5: kind of.
- 1:23:52Speaker 3: Broke it down into nice nine.
- 1:23:54Speaker 11: Chapters, and there's a conclusion chapter of things like fundamental
- 1:24:00Speaker 11: frameworks that pharmacies can use to grow from a job
- 1:24:06Speaker 11: into a business, right.
- 1:24:07Speaker 2: So that's incredible. That's a good preview. We will have
- 1:24:14Speaker 2: a link in the show notes to get you there.
- 1:24:18Speaker 2: We'll make sure that we're getting you back in touch
- 1:24:21Speaker 2: with tj M Labs.
- 1:24:24Speaker 4: That's t j M.
- 1:24:27Speaker 2: Labs dot com. What pharmacy conferences are you coming up on?
- 1:24:33Speaker 2: Because I think we're actually attending several together. You're going
- 1:24:38Speaker 2: to be going to which one next?
- 1:24:40Speaker 5: Yeah?
- 1:24:41Speaker 11: So we as a company are going to the Pennsylvania
- 1:24:45Speaker 11: Pharmacy Association of Pharmacies. That's coming up, I believe in
- 1:24:50Speaker 11: two weeks in February. There's also the NCBA Multi Store Conference.
- 1:24:55Speaker 5: In March. We have three conferences.
- 1:24:57Speaker 11: We have the Alliance of Pharmacy Compounding, We have the
- 1:25:00Speaker 11: Pharmacy Profit Summit.
- 1:25:03Speaker 5: We also have a TREM twenty four.
- 1:25:06Speaker 11: I am a banelist or a speaker and two of
- 1:25:09Speaker 11: these conferences.
- 1:25:10Speaker 5: We're also doing.
- 1:25:13Speaker 11: A podcast with the Alliance of Pharmacy Compounding just before
- 1:25:17Speaker 11: the conference. So we should hear a lot from us
- 1:25:20Speaker 11: in the coming few days. And obviously that I know
- 1:25:23Speaker 11: you're very active in the conference circle, so you're probably
- 1:25:25Speaker 11: going to be in all of these conferences.
- 1:25:28Speaker 5: But the idea for us is we know our product work.
- 1:25:31Speaker 11: Well, you know, lots of pharmacies kind of give us
- 1:25:35Speaker 11: great feedback. And the idea is we.
- 1:25:38Speaker 5: Want to know.
- 1:25:39Speaker 11: We want to let people know that this exists, that
- 1:25:42Speaker 11: AI is here. It's been here for two and a
- 1:25:44Speaker 11: half years.
- 1:25:44Speaker 5: It is not new, it is.
- 1:25:46Speaker 11: Not experimental at this point, there is. We feel like
- 1:25:52Speaker 11: Lisa Fast, who's.
- 1:25:54Speaker 5: An advisor to our company, likes to say AI or die.
- 1:25:58Speaker 5: And maybe it was.
- 1:26:00Speaker 11: Hyperbowl a year ago or two years ago, but it's
- 1:26:04Speaker 11: not anymore right, and it is truly the next stage
- 1:26:08Speaker 11: of any business. It's not just pharmacy where you have
- 1:26:12Speaker 11: to automate and you have to have good infrastructure to
- 1:26:17Speaker 11: scale as you move forward, where everything like AI is
- 1:26:23Speaker 11: basically in everything that you do, every product and in
- 1:26:27Speaker 11: every interaction, there's going to be some kind of AI
- 1:26:29Speaker 11: in it.
- 1:26:30Speaker 2: All right, Yeah, but here's here's my pushback to you
- 1:26:35Speaker 2: for just you see, you came on twerks thinking it
- 1:26:39Speaker 2: was going to.
- 1:26:39Speaker 4: Be softball stuff.
- 1:26:42Speaker 5: I like it, all right.
- 1:26:44Speaker 2: The difference between I'm trying to build a specialty pharmacy,
- 1:26:49Speaker 2: I have an infusion arm to it. I have a
- 1:26:53Speaker 2: special relationship with a network of physicians that know me,
- 1:26:56Speaker 2: trust me, I want to make some deviations. I want
- 1:27:01Speaker 2: to go into a different disease state. I get to
- 1:27:04Speaker 2: come to an organization that already understands that language, the positioning,
- 1:27:10Speaker 2: the structure, the clinical the freaking You're a pharmacist, for
- 1:27:16Speaker 2: God's sakes.
- 1:27:16Speaker 4: You have pharmacics on your team. You have all this
- 1:27:19Speaker 4: contextual structure. So here's the thing.
- 1:27:21Speaker 2: Just like anything with the invention, the invention of the wheel, right,
- 1:27:26Speaker 2: everybody got the wheel. It was the people that knew
- 1:27:29Speaker 2: how to use that wheel in a very specific manner
- 1:27:32Speaker 2: for a very specific job and for a very specific position.
- 1:27:36Speaker 2: And if you go out to just any old AI, oh,
- 1:27:38Speaker 2: I'll do it myself, And you're like, are you kidding me? Like,
- 1:27:44Speaker 2: get involved with organizations who understand the outcomes because they've
- 1:27:48Speaker 2: already tried it in very specific instances that pharmacology came
- 1:27:55Speaker 2: into play and being able to leverage that.
- 1:27:58Speaker 5: Yeah, no percent.
- 1:28:00Speaker 11: I mean, if you ask me today, what makes your
- 1:28:03Speaker 11: company different than the million AI companies that are sprouting
- 1:28:07Speaker 11: is the domain expertise. So we have about like fifty
- 1:28:11Speaker 11: five people in a company today. Forty five of these
- 1:28:15Speaker 11: are user, a pharmacist, or an engineer. So we have
- 1:28:20Speaker 11: whenever we run an implementation or work was a pharmacy,
- 1:28:23Speaker 11: there's a pharmacist running the show.
- 1:28:25Speaker 5: They're the project manager, right.
- 1:28:27Speaker 11: And the only way it would work is this way,
- 1:28:30Speaker 11: because you cannot replace domain expertise. You cannot have someone
- 1:28:35Speaker 11: who's been working in a pharmacy and understand all the rules,
- 1:28:37Speaker 11: the nuances, the edge cases for ten years.
- 1:28:40Speaker 5: There's just no way you can replace that experience with
- 1:28:42Speaker 5: anything else.
- 1:28:44Speaker 2: So I also want to just make reference to when
- 1:28:48Speaker 2: we bring a lot of things to twerks, we always
- 1:28:52Speaker 2: like to bring people that have vision then not just
- 1:28:57Speaker 2: building something amazing and not just doing what you're doing,
- 1:29:00Speaker 2: which I'm kind of preparing for the future. So I'm
- 1:29:03Speaker 2: sharing with the listeners now that on the blog right
- 1:29:06Speaker 2: before as the hall. It's so funny when when content
- 1:29:11Speaker 2: and when announcements come come out during the Christmas season,
- 1:29:16Speaker 2: like everybody like ignores what the heck's going on, and
- 1:29:19Speaker 2: then when we get back and by the time we
- 1:29:21Speaker 2: hit February, like we're ready, We're all ready to build
- 1:29:24Speaker 2: business like right now, right there was there was a
- 1:29:27Speaker 2: press release that came out on December twenty ninth, like
- 1:29:30Speaker 2: who releases on December twenty ninth.
- 1:29:33Speaker 4: Goodness, gracious, everybody's like in Christmas mode.
- 1:29:37Speaker 2: But fighting is you guys, closed ten million dollar series
- 1:29:42Speaker 2: led by Arthur Ventures. Congratulations. But the reason why I'm
- 1:29:45Speaker 2: excited about this is we get to we get to
- 1:29:48Speaker 2: take our positioning as a profession by being able to
- 1:29:52Speaker 2: partner with organizations that have that domain expertise and over
- 1:29:57Speaker 2: and over again, get to tap into, yeah, the understanding
- 1:30:01Speaker 2: of what it means to be a pharmacist in a
- 1:30:03Speaker 2: very specific situation.
- 1:30:05Speaker 11: Yeah, And we called this in our book, right, So
- 1:30:08Speaker 11: obviously we were racing to close our seriesa before the
- 1:30:10Speaker 11: year end just because of tax reasons and all of
- 1:30:13Speaker 11: that stuff, but we call it in our book. One
- 1:30:16Speaker 11: of the chapters is about if you have something that
- 1:30:19Speaker 11: is working. Most people mistake is not sink big enough, right, Like,
- 1:30:24Speaker 11: if you have a pharmacy and the pharmacy is successful
- 1:30:26Speaker 11: and it's growing, that's it, right. They don't think, Okay,
- 1:30:30Speaker 11: what is like, how could it be then x bigger?
- 1:30:32Speaker 11: How could it be one hundred x bigger?
- 1:30:34Speaker 1: Right?
- 1:30:34Speaker 11: And if you look at the pharmacy kind of landscape. Unfortunately,
- 1:30:38Speaker 11: let's just talk about pharmacy management system. The average pharmacy
- 1:30:42Speaker 11: management system is like twenty years old, right. It is
- 1:30:46Speaker 11: dominated by private equity, you know, financially incentivized companies that
- 1:30:52Speaker 11: don't really like to invest in their software. They like
- 1:30:55Speaker 11: to extract rent and basically have you bay your monthly fees,
- 1:31:00Speaker 11: really giving anything back and improving the software. There haven't
- 1:31:04Speaker 11: been any serious investment in the pharmacy ecosystem. A lot
- 1:31:09Speaker 11: of companies start trying to build per phormacies, but they
- 1:31:11Speaker 11: don't have the domain expertise and they basically pivot to
- 1:31:15Speaker 11: do something else. Luckily for us, we have the domain expertise.
- 1:31:19Speaker 11: We do have the engineering expertise as well, not only
- 1:31:21Speaker 11: in a pharmacist and also an engineer.
- 1:31:24Speaker 5: And it is the right time.
- 1:31:26Speaker 11: We think AI can be transformed transformative. If you just
- 1:31:31Speaker 11: look at the public companies today, software companies there are
- 1:31:34Speaker 11: basically being destroyed because everybody looks at AI companies and
- 1:31:39Speaker 11: they say, hey, they can move ten times faster and
- 1:31:42Speaker 11: they can give us like better product. And not only
- 1:31:45Speaker 11: it's not just software where someone has to go and
- 1:31:47Speaker 11: click and do things, but it's software that just essentially
- 1:31:51Speaker 11: does the work for you. Right, So today, like in pharmacy,
- 1:31:54Speaker 11: you go in, you buy I don't know some soft
- 1:31:57Speaker 11: dashboard pharmacy dashboard that show you stuff. You still have
- 1:32:00Speaker 11: to go in and you have to read and you
- 1:32:02Speaker 11: have to come up with what they're going to do
- 1:32:04Speaker 11: with that data.
- 1:32:05Speaker 5: But AI companies function a little bit different.
- 1:32:08Speaker 11: They say, we are going to look at all the data,
- 1:32:11Speaker 11: We're going to identify the interventions, right, and we're going
- 1:32:14Speaker 11: to give it to you an end and you have
- 1:32:15Speaker 11: to approve, right.
- 1:32:16Speaker 5: And that's the difference.
- 1:32:17Speaker 11: When we do our automation, it's literally the view prescriptions
- 1:32:20Speaker 11: come in, the facts come in, how our team sits
- 1:32:22Speaker 11: with you, gets all the details, the nuances, what is
- 1:32:25Speaker 11: different about your parmacy and everybody else, and then the
- 1:32:28Speaker 11: boche's works in the background. That's it, right, So it's
- 1:32:33Speaker 11: going to be a very exciting time over the next
- 1:32:35Speaker 11: three to five years.
- 1:32:36Speaker 2: I would say, So, you know, that's it's great when
- 1:32:42Speaker 2: you hear it from you know, the leadership level, someone
- 1:32:45Speaker 2: at your level, the CEO that's leading the company. But
- 1:32:49Speaker 2: then if I jump into a team that surrounds you,
- 1:32:54Speaker 2: you got to bring heavy hitters, and you have to
- 1:32:57Speaker 2: bring once again, domain not domain knowledge. Because I'm not
- 1:33:02Speaker 2: a good CEO. I think I'd be good at business development.
- 1:33:05Speaker 2: You know, I lead this publication, but I know my
- 1:33:08Speaker 2: weaknesses and I know my strengths, and you being able
- 1:33:11Speaker 2: to leverage a dream team of people who have domain
- 1:33:14Speaker 2: experience kind of give a quick overview. We'll have separate
- 1:33:18Speaker 2: we'll have other twerques out there that will feature these people.
- 1:33:21Speaker 4: But talk to me about Meghan and.
- 1:33:24Speaker 2: NASA and mister Ross Miller at a little bit more
- 1:33:28Speaker 2: about the team.
- 1:33:29Speaker 5: Yeah, so these guys are the dream team.
- 1:33:31Speaker 11: Basically we At some point your job as a CEO
- 1:33:36Speaker 11: transforms from doing things to building the team that builds
- 1:33:41Speaker 11: the team if you look.
- 1:33:44Speaker 5: So.
- 1:33:44Speaker 11: Meghan is a pharmacist. She was our first employee ever.
- 1:33:48Speaker 11: She has experience in user experience and design, which again
- 1:33:52Speaker 11: very very rare for pharmacists. She truly thinks about how
- 1:33:55Speaker 11: could we make the experience of the people on the
- 1:33:59Speaker 11: front line as exceptional as possible?
- 1:34:04Speaker 5: Right, And the company.
- 1:34:07Speaker 11: Was basically built while she was in the front line,
- 1:34:10Speaker 11: very early on. Abdullah is our engine director of engineering.
- 1:34:14Speaker 11: Now he was our surge employee. He took over, so
- 1:34:17Speaker 11: I started as the first engineer and he took over
- 1:34:19Speaker 11: every single I do, and he runs our engineering department.
- 1:34:22Speaker 11: Now again we are we take a lot of pride
- 1:34:26Speaker 11: in our engineering where it is.
- 1:34:32Speaker 5: There's still was.
- 1:34:33Speaker 11: AI now, like you can generate a lot of code
- 1:34:36Speaker 11: really quickly, but there's that craftsmanship.
- 1:34:39Speaker 5: We called it pharmaceutical elegance.
- 1:34:41Speaker 11: Like if you're in the pharmacy and you're doing compounding,
- 1:34:44Speaker 11: you can just mix a compound really.
- 1:34:45Speaker 2: Couill listen, my dad was an electrician. Every electrician, the
- 1:34:50Speaker 2: people that had two hours of experience and the people
- 1:34:53Speaker 2: that had, you know, eighty years of experience. You gave
- 1:34:55Speaker 2: him a screwdriver, right, yes, already had the same screwdriver.
- 1:34:59Speaker 2: How are you I kind of use that screwdriver better?
- 1:35:02Speaker 2: And you know that's some analogy, but it's definitely AI
- 1:35:06Speaker 2: toot on hand.
- 1:35:08Speaker 5: Yes, there's the craftsmanship.
- 1:35:10Speaker 11: I think you're never going to be able to take
- 1:35:11Speaker 11: that away, which you see it in pharmacies was pharmaceutical elegance.
- 1:35:15Speaker 11: Hannah is basically our implementation superstar, right, so she manages
- 1:35:21Speaker 11: all implementations very you know, just a pharmacist loves pharmacy,
- 1:35:27Speaker 11: really works well with other pharmacies. Sometimes some pharmacies are organized,
- 1:35:32Speaker 11: sometimes they're not organized, but we take them all and
- 1:35:35Speaker 11: you probably saw us and LinkedIn. He's very very active
- 1:35:38Speaker 11: comes from enterprise software. Has been on Monday dot Com,
- 1:35:42Speaker 11: have been in Microsoft fifteen years if basically doing sales,
- 1:35:48Speaker 11: and he's our VP of sales now and he's basically
- 1:35:50Speaker 11: building a whole sales org under them. So I would say,
- 1:35:55Speaker 11: you know, some of it is luck. Definitely, Sometimes you
- 1:35:59Speaker 11: hire people, things do not work out. But I would
- 1:36:01Speaker 11: say our first forty or so employees have been all
- 1:36:05Speaker 11: been exceptional and in the life of the company we
- 1:36:08Speaker 11: have not lost We only lost two people out of
- 1:36:10Speaker 11: fifty five, which is again exceptional retention. So you know,
- 1:36:15Speaker 11: hopefully we can continue this way so well.
- 1:36:18Speaker 2: When you find people that are part of a mission,
- 1:36:21Speaker 2: it becomes more than just a job. It becomes something
- 1:36:24Speaker 2: that you really want to have an impact. And that's
- 1:36:27Speaker 2: that's the way I feel about publishing. That's why I
- 1:36:29Speaker 2: was working a full time position up until twenty nineteen
- 1:36:33Speaker 2: and doing a podcast development and publishing on the side,
- 1:36:37Speaker 2: and I had to decide, Hey, if this is ever
- 1:36:39Speaker 2: going to become something, it's time to do it. One
- 1:36:42Speaker 2: hundred percent of my dedication yea to empower other people.
- 1:36:46Speaker 2: And that's exactly what you're doing as the leader at
- 1:36:48Speaker 2: TGM Labs. You're You're literally the guy who's supporting all
- 1:36:52Speaker 2: of them. They're coming to you to become enhanced, and
- 1:36:55Speaker 2: then your client is also doing the exact same thing.
- 1:36:59Speaker 2: So I absolutely love this domino effect of what's happening.
- 1:37:04Speaker 2: And it's an exciting time to be in the profession.
- 1:37:07Speaker 4: I'll tell you that, Yeah, it is.
- 1:37:09Speaker 5: Yeah.
- 1:37:09Speaker 11: And you know, as a CEO, you have to fire
- 1:37:12Speaker 11: yourself from a job every three months, literally, like you know,
- 1:37:15Speaker 11: so I know we've we've been doing that. So I'm
- 1:37:19Speaker 11: looking forward to firing myself from some of the legal
- 1:37:22Speaker 11: and Bible work stuff that I have to do now,
- 1:37:24Speaker 11: so that would be exciting.
- 1:37:27Speaker 2: Well, it's so good to have you. I've been looking
- 1:37:29Speaker 2: forward to getting you on twerks. We're excited to do
- 1:37:34Speaker 2: some other future interviews. Every single one of the conferences
- 1:37:37Speaker 2: I think that you're mentioning. I think we're almost going
- 1:37:40Speaker 2: to all of them. So we're going to make sure
- 1:37:42Speaker 2: that we get you back on the shows to give
- 1:37:44Speaker 2: us some insights.
- 1:37:45Speaker 4: And I got to get Ross on. I need to
- 1:37:47Speaker 4: talk to him. I really enjoy his style.
- 1:37:50Speaker 2: I'm kind of like more of a I'm closer to
- 1:37:53Speaker 2: a Ross and personality of Ross than I am with you, Jonathan,
- 1:37:58Speaker 2: just just to be upfront, because I I like one.
- 1:38:00Speaker 4: Hundred percent marketing.
- 1:38:02Speaker 5: I'm a bret nerd. Right, I'm a big nerd. We
- 1:38:05Speaker 5: can talk about engineering all day long. Right, And you know, I.
- 1:38:10Speaker 11: Think we missed really well as a group. So Meghan
- 1:38:12Speaker 11: is like pursue of excellence. She's super detailed oriented, has
- 1:38:16Speaker 11: this like very artistic good taste. Right, I'm not I
- 1:38:21Speaker 11: don't have good taste, like what color is that? Shoul
- 1:38:23Speaker 11: choose all lot of stuff. Ross doesn't have either, And
- 1:38:27Speaker 11: I think I'm a big, big nerd right. And Ross
- 1:38:30Speaker 11: is very very like outgoing and social and likes to
- 1:38:32Speaker 11: talk to people.
- 1:38:33Speaker 5: So good group to work with.
- 1:38:35Speaker 4: So I tell you what it's.
- 1:38:40Speaker 2: I think of the possibilities of what's going to happen
- 1:38:45Speaker 2: over the next two to five years, and how pharmacy
- 1:38:47Speaker 2: is going to look so vastly different and excited to
- 1:38:51Speaker 2: a scene where it came from.
- 1:38:53Speaker 4: It's so fun.
- 1:38:54Speaker 2: We've been podcasting seventeen years to be able to track
- 1:38:58Speaker 2: what is what was the profession like seventeen years ago?
- 1:39:01Speaker 2: And I'm going to start cataloging a lot of that
- 1:39:03Speaker 2: information so that you can kind of look back to
- 1:39:06Speaker 2: the history of our profession based on, you know, launching
- 1:39:10Speaker 2: the industry's first podcast in two thousand and nine.
- 1:39:13Speaker 5: Yeah, that's amazing.
- 1:39:15Speaker 11: Seventeen years, right the podcast was a kid, they would
- 1:39:19Speaker 11: be ready to go to college.
- 1:39:21Speaker 4: That's true.
- 1:39:22Speaker 2: And you know what, this this beast of a thing
- 1:39:25Speaker 2: that I've worked on for seventeen years. It's time to
- 1:39:27Speaker 2: get kick his ass out and make making his father.
- 1:39:30Speaker 5: Money exactly right.
- 1:39:32Speaker 1: So that's what I'm doing.
- 1:39:33Speaker 2: I have the most important question of our podcast today
- 1:39:36Speaker 2: on Twitch.
- 1:39:37Speaker 4: So I'm going to ask.
- 1:39:38Speaker 2: You is who are you voting for in the Super
- 1:39:42Speaker 2: Bowl this weekend?
- 1:39:43Speaker 5: Oh man?
- 1:39:44Speaker 11: So I want to Basically grew up in New York, right,
- 1:39:48Speaker 11: and my first experience was football was watching the Giants
- 1:39:51Speaker 11: beat the Patriots like every time they played in the
- 1:39:54Speaker 11: Super Bowl. So there's no way I can cheer for
- 1:39:56Speaker 11: the Patriots.
- 1:39:57Speaker 2: Nice, we're all the same team, Listen. I have selfish reasons,
- 1:40:02Speaker 2: So I don't want the Patriots to get more Super
- 1:40:05Speaker 2: Bowl rings than the Pittsburgh Steelers because it's I'm a
- 1:40:08Speaker 2: Steelers fan, so I'll vote for anyone else. And by
- 1:40:11Speaker 2: the way, if you think about it, there were some
- 1:40:15Speaker 2: very bad calls in the Super Bowl between the Seahawks
- 1:40:18Speaker 2: and the Steelers.
- 1:40:19Speaker 4: I feel it's like this, it's their turn to, you.
- 1:40:23Speaker 2: Know, get it, because there are just a couple of
- 1:40:25Speaker 2: things you know that I even questionable as a Steeler fan.
- 1:40:29Speaker 4: But I'm excited this weekend. I don't want to see
- 1:40:33Speaker 4: football go. I'm a football guy.
- 1:40:35Speaker 11: Yeah, I mean, you know, neon'ng Glad have been winning
- 1:40:37Speaker 11: too many Super Bowls. Respect a hustle, right, you know, respect,
- 1:40:40Speaker 11: you know what they're doing, but enough, you know, they
- 1:40:43Speaker 11: don't want enough with someone else.
- 1:40:45Speaker 2: The Pittsburgh Steelers need ai. They need like a TJM.
- 1:40:49Speaker 2: Labs to come in and revitolize everything because it's kind
- 1:40:54Speaker 2: of a mishmash pish pash.
- 1:40:55Speaker 4: Who knows which ash situation right now?
- 1:40:59Speaker 11: Well, actually that's so, that's a badge. We need to
- 1:41:01Speaker 11: earn get one of the sports team pharmacies. We have
- 1:41:04Speaker 11: the Congress pharmacy, right, we have some of.
- 1:41:07Speaker 4: The sports pharmacy too. We have that guy in Miami.
- 1:41:11Speaker 11: We don't we don't have a football team pharmacy, but
- 1:41:15Speaker 11: we'll go out and find one.
- 1:41:16Speaker 5: So all right, I'll.
- 1:41:20Speaker 1: Take it exactly.
- 1:41:23Speaker 2: All right, Well, I wish you a wonderful weekend. Thank
- 1:41:26Speaker 2: you so much for being a guest on this Week
- 1:41:28Speaker 2: in Pharmacy, and we're gonna we're gonna talk more. We're
- 1:41:32Speaker 2: gonna have you back. We got we've got a lot
- 1:41:34Speaker 2: of subjects that we can dive into.
- 1:41:36Speaker 11: Awesome DoD Yeah, I'm very excited to always come back
- 1:41:38Speaker 11: and talk. So thank you for for hosting me.
- 1:41:41Speaker 4: All Right, you've been listening, Towers. Here we go, No